<SEC-DOCUMENT>0001178913-25-002396.txt : 20250717
<SEC-HEADER>0001178913-25-002396.hdr.sgml : 20250717
<ACCEPTANCE-DATETIME>20250717083020
ACCESSION NUMBER:		0001178913-25-002396
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250717
FILED AS OF DATE:		20250717
DATE AS OF CHANGE:		20250717

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GILAT SATELLITE NETWORKS LTD
		CENTRAL INDEX KEY:			0000897322
		STANDARD INDUSTRIAL CLASSIFICATION:	RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21218
		FILM NUMBER:		251128951

	BUSINESS ADDRESS:	
		STREET 1:		C/O GILAT SATELLITE NETWORKS INC
		STREET 2:		1651 OLD MEADOW RD
		CITY:			MCLEAN
		STATE:			VA
		ZIP:			22102
		BUSINESS PHONE:		7037349401

	MAIL ADDRESS:	
		STREET 1:		GILAT HOUSE YEGIA KAPAYIM STREET
		STREET 2:		DANIV PARK
		CITY:			KIRYAT ARYE PETAH TI
		STATE:			L3
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2533450.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">FORM 6 &#8211; K</div>
        <div style="line-height: 1.25; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-style: normal; font-variant: normal; text-transform: none;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND EXCHANGE COMMISSION</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25;">Washington, D.C. 20549</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25;">Report on Foreign Issuer</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25;">Pursuant to Rule 13a &#8211; 16 or 15d &#8211; 16</div>
        <div style="text-align: center; line-height: 1.25;">of the Securities Exchange Act of 1934</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25;">For the Month of July 2025</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;"><u>Gilat Satellite Networks Ltd.</u></div>
        <div style="text-align: center; line-height: 1.25;">(Translation of Registrant&#8217;s Name into English)</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25;">Gilat House, 21 Yegia Kapayim Street</div>
        <div style="text-align: center; line-height: 1.25;">Daniv Park, Kiryat Arye, Petah Tikva 4913020, Israel</div>
        <div style="text-align: center; line-height: 1.25;">(Address of Principal Corporate Offices)</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Form 20-F <font style="font-family: 'Segoe UI Symbol',sans-serif;">&#9746;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Form 40-F <font style="font-family: 'Segoe UI Symbol',sans-serif;">&#9744;</font></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange
          Act of 1934.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25;">Yes <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160;&#160; No <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">If &#8220;Yes&#8221; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):&#160;&#160; <u>N/A</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">Attached hereto is Registrant&#8217;s release dated July 17, 2025, announcing the Proxy Statement for Gilat Satellite Networks&#8217; Annual General Shareholders&#8217; Meeting.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">Signature</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <table cellspacing="0" cellpadding="0" id="z90e1199e959a4827ac8eacea5f262826" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 49.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
              <td style="width: 38.09%; vertical-align: top;" colspan="2">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">Gilat Satellite Networks Ltd.</div>
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">(Registrant)</div>
              </td>
              <td style="width: 11.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
              <td style="width: 3.13%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
              <td style="width: 34.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
              <td style="width: 11.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">Dated July 17, 2025</div>
              </td>
              <td style="width: 3.13%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">By:</div>
              </td>
              <td nowrap="nowrap" style="width: 34.96%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">/s/ Doron Kerbel</div>
              </td>
              <td style="width: 11.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
              <td style="width: 3.13%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
              <td nowrap="nowrap" style="width: 34.96%; vertical-align: bottom;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">Doron Kerbel</div>
              </td>
              <td style="width: 11.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
              <td style="width: 3.13%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
              <td style="width: 34.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">General Counsel &amp; Company Secretary</div>
              </td>
              <td style="width: 11.96%; vertical-align: top;">
                <div style="margin-right: 0.1pt; margin-left: 0.1pt; line-height: 1.25;">&#160;</div>
              </td>
            </tr>

        </table>
        <br>
        <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">GILAT SATELLITE NETWORKS LTD.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Gilat House</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">21 Yegia Kapayim St.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Kiryat Arye</div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Petah Tikva 4913020, Israel</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">To be held on August 14, 2025</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">To our Shareholders:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We cordially invite you to the Annual&#160;General Meeting of Shareholders of Gilat Satellite Networks Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) to be held at our
      offices at 21 Yegia Kapayim Street, Kiryat Arye, Petah Tikva 4913020, Israel, on August 14, 2025 at 12:00 p.m. Israel time for the following purposes (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;):</div>
    <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z207e733b1222454087fea14ee059c771" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to set the number of directors serving on the Board of Directors at eight;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z8f633743e0cb4866acaae7c94e6b0ff4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to re-elect four members of the Board of Directors and elect one new member of the Board of Directors to serve until the Company&#8217;s next annual general meeting of shareholders and until their successors have been duly elected and qualified;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4fa6ecbf822c48b381416f41fefd8921" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 53.85pt;"><br>
          </td>
          <td style="width: 17.85pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>subject to her election pursuant to Item No. 2, to approve a grant of options to Dana Porter Rubinshtein, as described in the Proxy Statement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4419f6c86415412597284e32be4b104b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to approve of the election of Hilla Haddad Chmelnik as an external director, as defined in the Israeli Companies Law 5759-1999 (the &#8220;<font style="font-weight: bold;">ICL</font>&#8221;), including the approval of her compensation terms, for a
              three-year period commencing as of the date of approval;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z4c9164cc86954236b561add1a24b6d29" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>subject to her election pursuant to Item No. 4, to approve a grant of options to Hilla Haddad Chmelnik, as described in the Proxy Statement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z51a8d97d7a8047d89aa0e3520c8604a5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 53.85pt;"><br>
          </td>
          <td style="width: 17.85pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to amend the Company&#8217;s Compensation Policy for Executive Officers and Directors, as described in the Proxy Statement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z705e7e728c294487b169b10594c0e54e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 53.85pt;"><br>
          </td>
          <td style="width: 17.85pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>subject to the amendment of the Company&#8217;s Compensation Policy for Executive Officers and Directors pursuant to Item No. 6, to approve the grant of Performance Stock Units (PSU) to Adi Sfadia, the Company&#8217;s Chief Executive Officer, as
              described in the Proxy Statement; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zb2ba7893bd0d41e285bb65a6cf2520d8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 53.85pt;"><br>
          </td>
          <td style="width: 17.85pt; vertical-align: top;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to ratify and approve the reappointment and compensation of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as our independent registered public accountants for the fiscal year ending December 31, 2025, and for such
              additional period until the next annual general meeting of shareholders.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, our consolidated financial statements for the year ended December 31, 2024, will be received and considered at the Meeting.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">Our Board of Directors recommends that you vote &#8220;<font style="font-weight: bold;">FOR</font>&#8221; all proposals under Items 1 through 8, which are described in the attached Proxy
      Statement.</div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">Shareholders of record at the close of business on July 16<u>,</u> 2025 (the &#8220;<font style="font-weight: bold;">Record Date</font>&#8221;), are entitled to notice of and to vote at the
      Meeting and any adjournments thereof. You can vote either by mailing in your proxy or in person by attending the Meeting. Only proxies that are received at the offices of the Company at 21 Yegia Kapayim Street, Kiryat Arye, Petah Tikva 4913020,
      Israel, no later than 10:00 a.m. Israel time, on August 14, 2025<font style="font-weight: bold; font-style: italic;">,</font> will be deemed received in a timely fashion and the votes therein recorded. If you attend the Meeting, you can revoke your
      proxy and vote your shares in person. Detailed proxy voting instructions are provided both in the proxy statement and on the enclosed proxy card. Shareholders who hold shares through members of the Tel Aviv Stock Exchange may also vote electronically
      via the electronic voting system of the Israel Securities Authority up to six hours before the time fixed for the Meeting.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">You should receive instructions about electronic voting from the Tel Aviv Stock Exchange member through which you hold your shares. Shareholders may send the Company position
      papers no later than August 4, 2025, and the last date for submitting a request to include a proposal in accordance with Section 66(b) of the ICL is July 17, 2025.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">According to Israel&#8217;s Companies Law Regulations (Confirmation of Ownership of Shares for Voting at the General Meeting), 2000, if a shareholder holds shares through a member of
      the Tel-Aviv Stock Exchange Ltd. (TASE Member) and the ordinary shares are registered in the name of such TASE Member on the books of our registration company, the shareholder may provide the Company, prior to the meeting, with a certification
      confirming his ownership of the ordinary shares on the record date. Such certification may be obtained at the TASE Member&#8217;s offices or may be sent to the shareholder by mail (subject to payment of the cost of mailing), at the election of the
      shareholder; provided that the shareholder&#8217;s request is submitted with respect to a specific securities account.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the Company&#8217;s Articles of Association, the quorum required for the Meeting consists of at least two shareholders present, in person or by proxy, who hold or represent
      between them at least 25% of the Company&#8217;s issued and outstanding share capital.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">The approval of each of the proposals requires the affirmative vote of a majority of the ordinary shares present, in person or by proxy, and voting on such proposal (not taking
      into consideration abstentions).&#160; In addition, in order to approve each of Items Nos. 4, 5, 6 and 7, the shareholders&#8217; approval must either (i) include at least a majority of the ordinary shares voted by shareholders who are not controlling
      shareholders (within the meaning of the ICL) and who are not shareholders who have a personal interest (within the meaning of the ICL) in the approval of such proposal, not taking into consideration abstentions, or (ii) be obtained such that the
      total ordinary shares of non-controlling shareholders and non-interested shareholders voted against such proposal do not represent more than two percent of the outstanding ordinary shares.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">In accordance with the Israeli Companies Regulations (Reliefs for Companies with Securities Listed on Foreign Stock Exchanges), 5760-2000, a shareholder submitting a vote for
      each of Items Nos. 4, 5, 6 and 7 is deemed to confirm to the Company that such shareholder does not have a &#8220;Personal Interest&#8221; in such Item and is not a &#8220;Controlling Shareholder&#8221; (as such terms are defined under the ICL), unless such shareholder had
      delivered the Company a notice in writing stating otherwise, no later than 10 a.m., Israel time, on August 14, 2025, to the attention of the Company&#8217;s Corporate Secretary, at our registered office in Israel, 21 Yegia Kapayim St., Kiryat Arye, Petah
      Tikva 4913020, Israel.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">Shareholders may also review the proxy statement at our principal executive offices stated above, upon prior notice and during regular working hours (telephone number:
      +972-925-2016) until the date of the Meeting. Copies of this notice, the proxy statement and the proxy card for the meeting will also be available at the following websites: <u>www.edgar.gov</u>, <u>http://www.tase.co.il/tase/</u>, <u>http://www.magna.isa.gov.il</u>
      (the distribution sites), and <u>http://www.gilat.com</u>.</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z1f489c0764334a3696f7b3b2bd9c7d80">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50.00%;">
              <div>&#160;
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By Order of the Board of Directors,</div>
                <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Doron Kerbel, General Counsel &amp; Corporate Secretary</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">July 17, 2025</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">- ii -<br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">GILAT SATELLITE NETWORKS LTD.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Gilat House</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">21 Yegia Kapayim St.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Kiryat Arye</div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Petah Tikva 4913020, Israel</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROXY STATEMENT</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">To be held on August 14, 2025</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This Proxy Statement is furnished to the holders of ordinary shares of Gilat Satellite Networks Ltd. (&#8220;<font style="font-weight: bold;">Gilat</font>&#8221;, &#8220;<font style="font-weight: bold;">we</font>&#8221;, &#8220;<font style="font-weight: bold;">our</font>&#8221; or the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) in connection with the solicitation of proxies by the Board of Directors of the Company for use at the Annual General Meeting
      of Shareholders of the Company to be held at our offices at 21 Yegia Kapayim Street, Kiryat Arye, Petah Tikva, Israel, on August 14, 2025, at 12:00 p.m. Israel time, and at any adjournment thereof, pursuant to the accompanying Notice of our 2025
      Annual General Meeting of Shareholders (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">This Proxy Statement and the enclosed Proxy Card are being mailed to our shareholders on or about July 17, 2025.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Purpose of the Annual General Meeting</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, our shareholders will be asked to vote upon the following matters:</div>
    <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z069ea471f46c4bd9b44038d7bf8d278d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to set the number of directors serving on the Board of Directors at eight;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z14dabe5804e346698dd2eca8383cb4ed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to re-elect four members of the Board of Directors and elect one new member of the Board of Directors to serve until the Company&#8217;s next annual general meeting of shareholders and until their successors have been duly elected and qualified;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfe0592acc8ff454f86e5460a4f5231f6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>subject to her election pursuant to Item No. 2, to approve a grant of options to Dana Porter Rubinshtein, as described in the Proxy Statement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze5515350bd3842c294185bd8809fc0bd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to&#160;approve of the election of Hilla Haddad Chmelnik as an external director, as defined in the Israeli Companies Law 5759-1999 (the &#8220;<font style="font-weight: bold;">ICL</font>&#8221;), including the approval of her compensation terms, for a
              three-year period commencing as of the date of approval;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z62fe3ee659274a55b014c9961e379e65" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>subject to her election pursuant to Item No. 4, to approve a grant of options to Hilla Haddad Chmelnik, as described in the Proxy Statement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zea0e560cfe824dee851d0981cd35425b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to amend the Company&#8217;s Compensation Policy for Executive Officers and Directors, as described in the Proxy Statement;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z45bcb28995204a5ea730f9a5a9cb26e1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>subject to the amendment of the Company&#8217;s Compensation Policy for Executive Officers and Directors pursuant to Item No. 6, to approve the grant of Performance Stock Units (PSU) to Mr. Adi Sfadia, the Company&#8217;s Chief Executive Officer, as
              described in the Proxy Statement; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9ed0de5e5bc14dc5b51e838d9b2c6afb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 54pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">8.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>to ratify and approve the reappointment and compensation of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as our independent registered public accountants for the fiscal year ending December 31, 2025, and for such
              additional period until the next annual general meeting of shareholders.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Voting at the Meeting</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Only holders of record of our ordinary shares, nominal value NIS 0.20 per share, as of the close of business on July 16, 2025, are entitled to notice of and to vote at the Meeting.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">You can vote your ordinary shares by attending the Meeting. If you do not plan to attend the Meeting, the method of voting will differ for shares held as a record holder, shares
      held in &#8220;street name&#8221; (through a broker, trustee or nominee in the United States) and shares held through a Tel-Aviv Stock Exchange, or TASE, member. Record holders of shares will receive proxy cards. Holders of shares in &#8220;street name&#8221; in the United
      States will receive voting instructions forms, which will be used to instruct their banks, brokers or other nominees as to how to vote, or, in the alternative, they can submit voting instructions via the internet, at www.proxyvote.com. Holders of
      shares in &#8220;street name&#8221; through a TASE member may vote via a proxy card or via the internet, but through a different procedure (as described below):</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z94d865e4c4834f46a8a2477900eb19b5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 22.5pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold;">Voting in Person</font>. If your shares are registered directly in your name with our transfer agent (i.e., you are a &#8220;registered shareholder&#8221;), you may attend and vote in person at the Meeting. If you are
              a beneficial owner of shares registered in the name of your broker, bank, trustee, or nominee (i.e., your shares are held in &#8220;street name&#8221;), you are also invited to attend the Meeting; however, to vote in person at the Meeting as a beneficial
              owner, you must first obtain a &#8220;legal proxy&#8221; from your broker, bank, trustee or nominee, as the case may be, authorizing you to do so.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z76e5a9e0252a44c0a185219c693a62da" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 22.5pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold;">Voting by Proxy.</font> If you are a shareholder of record (that is, you hold a share certificate that is registered in your name or your shares are registered in your name in book-entry form in the Direct
              Registration System), you may submit your vote by proxy card by mail by completing, signing, and mailing the enclosed proxy card in the enclosed postage-paid envelope or, for shares held in street name, by following the voting instructions
              provided by your broker, bank, trustee, or nominee. The proxy must be received by our transfer agent or at our registered office in Israel by no later than 10:00 a.m. Israel time, on August 14, 2025, to be validly included in the tally of
              ordinary shares voted at the Meeting. Upon the receipt of a properly signed and dated proxy in the form enclosed, the persons named as proxies therein will vote the ordinary shares represented thereby in accordance with the instructions of
              the shareholder indicated thereon or, if no direction is indicated, in accordance with the recommendations of our Board of Directors.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z7b4923af0f994d9f9bd6b83085212134" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 22.5pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold;">Shareholders Holding in &#8220;Street Name&#8221; in the United States.</font> If you hold ordinary shares in &#8220;street name,&#8221; that is, you are an underlying beneficial holder who holds ordinary shares through a bank,
              broker or other nominee, the voting process will be based on you directing the bank, broker or other nominee to vote the ordinary shares in accordance with your voting instructions. In order to provide voting instructions, you may submit a
              physical voting instruction form (if you have received one) in the enclosed envelope, or an online voting instruction form (at www.proxyvote.com ). Your voting instructions must be received by 11:59 p.m., Eastern time, on August 13, 2025, to
              be validly implemented and reflected in the tally of ordinary shares voted at the Meeting. Because a beneficial owner is not a shareholder of record, you may not vote your shares directly at the Meeting unless you obtain a &#8220;legal proxy&#8221; from
              the bank, broker or nominee that holds your shares, giving you the right to vote the shares at the Meeting. You will also need an account statement dated on or about the Record Date that shows that you hold ordinary shares in your bank,
              brokerage or other account in order to vote in person at the Meeting.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 22.5pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>
                <div style="line-height: 1.25;">Where a beneficial owner has executed and returned a voting instruction form, but has not provided voting instructions with respect to any or all proposals, the broker, trustee or nominee may not cast a vote
                  with respect to those proposal(s) (commonly referred to as a &#8220;broker non-vote&#8221;). In that scenario, the shares held by the beneficial owner will be included in determining the presence of a quorum at the Meeting, but will not be considered
                  &#8220;present&#8221; for the purpose of voting on those particular proposals. Those shares will therefore have no impact on the outcome of the voting on those particular proposals.</div>
              </div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; text-indent: -18pt; margin-left: 40.5pt; line-height: 1.25;"> <br>
      </div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="za1d021b0f4c742749e145fc6a87db33a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 22.5pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div><font style="font-weight: bold;">Shares Traded on the Tel Aviv Stock Exchange (&#8220;TASE&#8221;).</font> Shareholders who hold shares through members of the TASE may vote in person or vote through the enclosed form of proxy by completing, signing,
              dating and mailing the proxy with a copy of their identity card, passport or certificate of incorporation, as the case may be, to the Company&#8217;s offices. Shareholders who hold shares through members of the TASE and intend to vote their shares
              either in person or by proxy must deliver to the Company an ownership certificate confirming their ownership of the Company&#8217;s shares on the Record Date, which must be certified by a recognized financial institution, as required by the Israeli
              Companies Regulations (Confirmation of Ownership of Shares for Voting at General Meeting), 5760-2000, as amended. Alternatively, shareholders who hold shares through members of the Tel Aviv Stock Exchange may vote electronically via the
              electronic voting system of the Israel Securities Authority up to six hours before the time fixed for the Meeting (9:00 a.m. Israel time). You should receive instructions about electronic voting from the TASE member through which you hold
              your shares.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Solicitation of Proxies</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">We will bear all expenses of this solicitation. In addition to the solicitation of proxies by mail, our directors, officers, and employees, without receiving additional
      compensation therefor, may solicit proxies by telephone, facsimile, in person, or by other means. We may also engage a professional proxy solicitation firm, the costs of which will be borne by us. Brokerage firms, nominees, fiduciaries, and other
      custodians have been requested to forward proxy solicitation materials to the beneficial owners of our ordinary shares held of record by such persons, and we will reimburse such brokerage firms, nominees, fiduciaries, and other custodians for
      reasonable out&#8209;of&#8209;pocket expenses incurred by them in connection therewith.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Revocation of Proxy</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If you are a registered shareholder, you may change your vote at any time prior to the exercise of authority granted in the proxy by delivering a timely written notice of
      revocation to our Corporate Secretary, by granting a new proxy bearing a later date, or by attending the Meeting and voting in person. Attendance at the Meeting will not cause your previously granted proxy to be revoked unless you specifically so
      request. If your shares are held in street name, you may change your vote by submitting new voting instructions to your broker, bank, trustee, or nominee or, if you have obtained a legal proxy from your broker, bank, trustee, or nominee, giving you
      the right to vote your shares, by attending the Meeting and voting in person.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Any written instrument revoking a proxy should be received no later than 10:00 a.m. Israel time, on August 14, 2025 at our registered office in Israel, 21 Yegia Kapayim St., Kiryat
      Arye, Petah Tikva 4913020, Israel or as provided on your proxy card.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Required Votes</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each of our ordinary shares is entitled to one vote on each matter to be voted on at the Meeting.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The approval of each of the proposals requires the affirmative vote of a majority of the ordinary shares present, in person or by proxy, and voting on such proposal (not taking
      into consideration abstentions).&#160; In addition, in order to approve each of Items Nos. 4, 5, 6 and 7, the shareholders&#8217; approval must either (i) include at least a majority of the ordinary shares voted by shareholders who are not controlling
      shareholders (within the meaning of the ICL) and who are not shareholders who have a personal interest (within the meaning of the ICL) in the approval of such proposal, not taking into consideration abstentions, or (ii) be obtained such that the
      total ordinary shares of non-controlling shareholders and non-interested shareholders voted against such proposal do not represent more than two percent of the outstanding ordinary shares.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Israeli Companies Regulations (Reliefs for Companies with Securities Listed on Foreign Stock Exchanges), 5760-2000, a shareholder submitting a vote for each
      of Items No4 through 7 is deemed to confirm to the Company that such shareholder does not have a &#8220;Personal Interest&#8221; in such Item and is not a &#8220;Controlling Shareholder&#8221; (as such terms are defined under the ICL), unless such shareholder had delivered
      the Company a notice in writing stating otherwise, no later than 10:00 a.m., Israel time, on August 14, 2025, to the attention of the Company&#8217;s Corporate Secretary, at our registered office in Israel, 21 Yegia Kapayim St., Kiryat Arye, Petah Tikva
      4913020, Israel..</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In tabulating the voting result for any particular proposal, shares that constitute broker non-votes and abstentions are not considered votes cast on that proposal, but they will
      be counted to determine if a quorum is present. Unsigned or unreturned proxies, including those not returned by banks, brokers, or other record holders, will not be counted for voting purposes.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Quorum</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The presence, in person or by properly executed proxy, of two or more shareholders holding shares conferring at least 25% of the Company&#8217;s voting power is necessary to constitute a
      quorum at the Meeting.&#160; If within one-half of an hour from the time appointed for the Meeting, a quorum is not present, the Meeting will be adjourned to the same day in the next week, at the same time and place, or to a such later day and at such
      other time and place as the Chairman of the Meeting may determine with the consent of a majority of the voting power present at the meeting, in person or by proxy, and voting on the question of adjournment.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Shares Outstanding</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As of July 16, 2025, the Record Date, the Company had 57,211,899 ordinary shares outstanding. Equiniti Trust Company, LLC is the transfer agent and registrar for our ordinary
      shares.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">AFTER CAREFUL CONSIDERATION, OUR BOARD OF DIRECTORS HAS APPROVED ALL THE PROPOSALS DESCRIBED IN THIS PROXY STATEMENT AND RECOMMENDS THAT OUR SHAREHOLDERS VOTE &#8220;FOR&#8221; EACH OF THE
      NOMINEES FOR DIRECTOR NAMED IN THIS PROXY STATEMENT AND &#8220;FOR&#8221; EACH OF THE OTHER PROPOSALS SET FORTH IN THIS PROXY STATEMENT.</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; text-indent: 39.7pt; line-height: 1.25; font-weight: bold;">ITEM I. TO SET THE NUMBER OF DIRECTORS SERVING ON THE BOARD OF</div>
      <div style="text-align: center; text-indent: 39.7pt; line-height: 1.25; font-weight: bold;"> DIRECTORS AT EIGHT</div>
    </div>
    <div style="text-align: center; line-height: 1.25;">(Item 1 on the Proxy Card)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with our Articles of Association, our Board of Directors will consist of not less than five and not more than nine directors, as may be fixed from time to time by our
      shareholders. Our shareholders last fixed the number of directors at seven. Our Board of Directors believes that a Board of Directors comprised of eight members is appropriate for our Company and therefore recommends to increase the size of our Board
      of Directors from seven to eight members.</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with our Articles of Association, any change to the total number of directors serving on our Board of Directors requires the approval of such change by our
        shareholders.</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 1)</font>&#160;<font style="font-weight: bold;">RESOLVED</font>, that the number of directors serving on the Company&#8217;s Board of Directors be set
      at eight.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented and voting on this proposal in person or by proxy is necessary to set the number of directors.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Board of Directors recommends a vote <font style="font-weight: bold;">FOR</font> the number of directors serving on the Company&#8217;s Board of Directors be set at eight.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; text-indent: 39.7pt; line-height: 1.25; font-weight: bold;">ITEM II. RE-ELECTION/ELECTION OF DIRECTORS</div>
    </div>
    <div style="text-align: center; line-height: 1.25;">(Item 2 on the Proxy Card)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each of our directors, with the exception of our external directors, serves from the annual general meeting in which he or she was appointed until the next annual general meeting
      and until that director&#8217;s successor is appointed, unless his or her office is earlier vacated under any relevant provision of the Articles of Association of the Company or the law.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with Israeli law and practice, our Board of Directors is authorized to recommend to our shareholders director nominees for election. Accordingly, our Board has
      nominated the four directors named below for re-election to our Board of Directors. We are unaware of any reason why any of the nominees if elected, would be unable to serve as a director. Each of the nominees listed below has advised our Board of
      Directors that he or she intends to serve as a director if elected.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our ESG and Nomination Committee&#160;recommended that four of our current directors, Amiram Boehm, Aylon (Lonny) Rafaeli, Dafna Sharir and Amir Ofek be re-elected, and that Dana Porter
      Rubinshtein be elected to the Board, and our Board of Directors subsequently approved the recommendation of the ESG and Nomination Committee&#160;and nominated the five nominees. If re-elected at the Meeting, Mr. Boehm shall continue to serve as Chairman
      of the Board of Directors following the Meeting. Ronit Zalman Malach, whose term of office expires at the Meeting, elected not to stand for reelection.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Company has two additional directors who serve as the Company&#8217;s &#8220;external directors&#8221; in accordance with the ICL, Elyezer Shkedy and Amikam (Ami) Shafran, whose term of office
      end in June 2026 and May 2027, respectively, and are not standing for reelection at the Meeting. In addition, as set forth in Item No. 4 below, Hilla Haddad Chmelnik is being nominated to serve as third external director.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the ICL, each of the nominees for election to our Board of Directors (as well as&#160;our external directors and nominee for a new external director) has certified to
      us that he or she meets all the requirements of the ICL for election as a director of a public company, and possesses the necessary qualifications and has sufficient time,&#160;to fulfill his or her duties as a director of the Company, taking into account
      the Company&#8217;s size and special needs.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">During the past year, all of our directors attended more than 75% of the meetings of our Board of Directors and more than 75% of the meetings of each of the Committees of the Board
      of Directors on which they serve.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Nominees for the Board of Directors of the Company</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is proposed that at the Meeting, each of the following persons be elected to serve as a member of the Company&#8217;s Board of Directors until the next annual general meeting of
      shareholders and until their successors have been duly elected and qualified.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following information concerning the nominees is based on the records of the Company and information furnished to it by the nominees: </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Amiram Boehm (53)</font>&#160;has served on our Board of Directors since December 2012 and as Chairman of the Board since March
      2023. From 2004 and until November 2022, Mr. Boehm was a Partner in the FIMI Opportunity Funds, Israel&#8217;s largest group of private equity funds. In February 2023, Mr. Boehm was appointed as Chairman of the Board of BrainsWay Ltd. (NASDAQ and TASE),
      and in May 2023, Mr. Boehm was appointed as a member of the Board of directors of Leumi Partners. While he was a Partner in the FIMI Opportunity, Mr. Boehm served as the Chairman of the Board of&#160;directors of DelekSon Ltd. and a director at, Hadera
      Paper Ltd. (TASE), Rekah Pharmaceuticals Ltd (TASE), KAMADA Ltd. (NASDAQ and TASE), TAT Technologies Ltd. (NASDAQ and TASE), PCB Technologies Ltd. (TASE), and Galam Ltd. Mr. Boehm previously served as the Managing Partner and Chief Executive Officer
      of FITE GP (2004), and as a director among others of Ormat Technologies Inc. (NYSE, TASE), Scope Metal Trading, Ltd. (TASE), Inter Industries, Ltd. (TASE), NOVOLOG (Pharm-Up 1966) Ltd. (TASE), Global Wire Ltd. (TASE), Telkoor Telecom Ltd. (TASE),
      Dimar Cutting Tools Ltd and Solbar Industries Ltd. (previously traded on the TASE). Prior to joining FIMI, from 1999 until 2004, Mr. Boehm served as Head of Research of Discount Capital Markets, the investment arm of Israel Discount Bank. Mr. Boehm
      holds a B.A. degree in Economics and a LL.B. degree from Tel Aviv University, Israel and a Joint M.B.A. degree from Northwestern University and Tel Aviv University, Israel.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Aylon (Lonny) Rafaeli (71)&#160;</font>has served on our Board of Directors since May 2016. Mr. Rafaeli&#160;is a strategy and&#160;business
      development manager and consultant. From 2007 through 2012, Mr. Rafaeli was Director of Business&#160;Development at MST, a concentrated photo voltaic company. Prior to joining MST, Mr. Rafaeli was Managing Partner at&#160;E. Barak Associates, a strategic
      consulting company. Mr. Rafaeli is a member of the board of directors of the TALI&#160;Education Fund and a veteran association of an IDF elite unit. Mr. Rafaeli also served in the past as a director of Lenox&#160;Investment and Azimuth Technologies. Mr.
      Rafaeli holds an Executive M.B.A. degree in Strategic Management from&#160;The Hebrew University of Jerusalem, Israel.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Dafna Sharir (56)</font>&#160;has served on our Board of Directors since May 2016. Since 2005, Ms. Sharir has served as
      an&#160;independent consultant in the areas of mergers and acquisitions and business development. Ms. Sharir has served as a&#160;director of Ormat Technologies Inc. (NYSE, TASE) since 2018, and as a director of Cognyte Software Ltd (NASDAQ,&#160;TASE) since 2022.
      She served as Senior Vice President Investments of Ampal Corp. between 2002 and 2005. Before&#160;that she served as Director of Mergers and Acquisitions at Amdocs (until 2002). Between 1994 and 1996, Ms. Sharir&#160;worked as a tax attorney with Cravath,
      Swaine &amp; Moore in New York. Ms. Sharir is a director of Ormat Technologies&#160;Inc., Minute Media Inc. and Cognyet Software Ltd. and served in the past as a director of Frutarom Industries Ltd. Ms.&#160;Sharir holds a B.A. degree in Economics and a LL.B
      degree, both from Tel Aviv University, Israel, LL.M. degree in Tax&#160;Law from New York University, and M.B.A. degree from INSEAD.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Amir Ofek (49)</font>&#160; has served on our Board of Directors since June 2023 and previously served as a director of our company
      from 2014 to 2019. Mr. Ofek&#160;has more than 20 years of professional experience in management and board positions in technology-based companies. Since 2021, Mr. Ofek serves as CEO of AxoniusX, an Axonius&#8217; company. Prior to that, between 2019 and 2021,
      Mr. Ofek was the CEO of Alcide IO Ltd. (acquired by Rapid7 Inc. - NASDAQ: RPD).&#160; Prior to that, between 2016 and 2019 Mr. Ofek served as the CEO of CyberInt Ltd. Mr. Ofek also held various leadership positions at Amdocs Ltd. (NASDAQ: DOX) and Elbit
      Systems Ltd. (NASDAQ and TASE: ESLT). Mr. Ofek was a Captain in the IDF 8200 Unit and holds a BSc. degree (Cum Laude) in IT Engineering from the Technion and an&#160;M.B.A. degree from INSEAD.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Dana Porter Rubinshtein (52) </font>has more than 20 years of professional experience as a marketing, product, and strategy
      executive in the high-tech industry. Ms. Porter Rubinshtein had served as a Board member of Rafael Advanced Defense Systems Ltd. between 2015 and 2017, and as a Board observer of Inception XR between May 2022 and March 2025, an&#160;XR platform which she
      co-founded in 2016 and was later sold to a training company for the healthcare industry. Ms. Porter Rubinshtein also serves on the Advisory Board of Sapiens International Corp NV (NASDAQ: SPNS) since February 2023, and as a Board member at
      Elem,&#160;Israel&#8217;s leading nonprofit supporting youth in distress, since May 2021. Prior to that, Ms. Porter Rubinshtein held senior management positions, including Head of Strategy and Marketing at the ILDC of Microsoft Corporation (NASDAQ: MSFT)
      between 2013 and 2016, and as Chief Marketing Officer of Amdocs Limited (NASDAQ: DOX) between 2010 and 2013, and other senior roles Amdocs between 2003 and 2010. Prior to Amdocs, Ms. Porter Rubinshtein was an international consultant at Deloitte and
      Teffen. Ms. Porter Rubinshtein holds a degree (B.Sc.) in Industrial Engineering from Ben-Gurion University and an MBA from New York University (NYU).</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Each of the director nominees has certified to the Company that he or she complies with all requirements under the ICL for serving as a director.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If re-elected, the terms of office of Mr. Boehm (the Company&#8217;s Chairman of the Board of Directors), Mr. Rafaeli, Ms. Sharir and Mr. Ofek will remain unchanged, including their
      entitlement to their indemnification and D&amp;O insurance coverage in accordance with the Company&#8217;s Compensation Policy for Executive Officers and Directors (the &#8220;<font style="font-weight: bold;">Compensation Policy</font>&#8221;).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If elected, Ms. Porter Rubinshtein&#8217;s terms of compensation will be identical to the terms of the other Board members (excluding the Company&#8217;s Chairman of the Board of Directors)
      and in accordance with the Company&#8217;s Compensation Policy.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolutions be adopted:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 2(a))</font>&#160;<font style="font-weight: bold;">RESOLVED</font>, to re-elect Mr. Amiram Boehm as member of the Board of Directors of the
      Company, to serve until the next annual general meeting of shareholders and until his successor has been duly elected and qualified;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 2(b))</font>&#160;<font style="font-weight: bold;">FURTHER RESOLVED</font>, to re-elect Mr. Aylon (Lonny) Rafaeli as member of the Board of
      Directors of the Company, to serve until the next annual general meeting of shareholders and until his successor has been duly elected and qualified;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 2(c))</font>&#160;<font style="font-weight: bold;">FURTHER RESOLVED</font>, to re-elect Ms. Dafna Sharir as member of the Board of Directors of
      the Company, to serve until the next annual general meeting of shareholders and until her successor has been duly elected and qualified;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 2(d))</font>&#160;<font style="font-weight: bold;">FURTHER RESOLVED</font>, to re-elect Mr. Amir Ofek as member of the Board of Directors of the
      Company, to serve until the next annual general meeting of shareholders and until his successor has been duly elected and qualified; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;<font style="font-style: italic;">(Item 2(e))</font>&#160;<font style="font-weight: bold;">FURTHER RESOLVED</font>, to elect Ms. Porter Rubinshtein as member of the Board of Directors
      of the Company, to serve until the next annual general meeting of shareholders and until her successor has been duly elected and qualified.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter, is required
      to approve the election of each of the director nominees named above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The&#160;Board of Directors recommends a vote <font style="font-weight: bold;">FOR</font> the election of each nominee for Director named above.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ITEM III.&#160;&#160; SUBJECT TO HER ELECTION PURSUANT TO ITEM NO. 2, TO APPROVE A </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">GRANT OF OPTIONS TO DANA PORTER RUBINSHTEIN, AS DESCRIBED IN THE PROXY STATEMENT</div>
      <div style="text-align: center; line-height: 1.25;">(Item 3 on the Proxy Card)</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the ICL, any arrangement between the Company and a director relating to his or her compensation as a director or other position with the Company must be in compliance with
      the Company&#8217;s Compensation Policy for Executive Officers and Directors and requires approval of the Compensation Committee, the Board of Directors and the Company&#8217;s shareholders, in that order.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is proposed that, in addition to the cash compensation paid to our directors, to grant options to purchase ordinary shares of the Company to Ms. Porter Rubinshtein.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Compensation Committee and Board of Directors approved and recommended granting its non-executive directors, including the Company&#8217;s external directors, upon their first
      appointment or appointment renewal (provided that there were no previously granted options at the grant date that remained unvested), options in the amount and under the conditions set and approved by the Compensation Committee, the Board of
      Directors, and reaffirmed by the Company&#8217;s shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Compensation Committee and Board of Directors approved and recommended that our shareholders approve the grant of options to purchase 50,000 of our ordinary shares to Ms.
      Porter Rubinshtein upon her election as a director.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the terms of our 2008 Stock Options Plan and the Company&#8217;s Compensation Policy for Executive Officers and Directors, the exercise price of the options to be granted to
      Ms. Porter Rubinshtein will be 5% over the closing price of the Company&#8217;s ordinary shares on the NASDAQ Global Select Market on the grant date, which is the second trading day following Meeting (August 15, 2025).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Similar to previous grants of options to other Company directors, the options will vest and become exercisable quarterly over a three-year period, so long as the director continues
      to serve as a director and will be exercisable for 12 months following cessation or termination of his or her service (other than for cause).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: -36pt; margin-left: 72pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 3)</font>&#160;<font style="font-weight: bold;">RESOLVED</font>, subject to her election under Item 2, to approve a grant of 50,000 options to
      Ms. Porter Rubinshtein, exercisable into ordinary shares of the Company as described in the Proxy Statement, upon her election as set forth in this Proxy Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented and voting on this proposal in person or by proxy is necessary to grant options to Ms. Porter
      Rubinshtein.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Board of Directors recommends a vote <font style="font-weight: bold;">FOR</font> the grant of options to Ms. Porter Rubinshtein the nominee for election as a director.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ITEM IV. TO APPROVE THE ELECTION OF HILLA HADDAD CHMELNIK AS AN</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"> EXTERNAL DIRECTOR, INCLUDING THE APPROVAL OF HER COMPENSATION TERMS, </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOR A THREE-YEAR PERIOD COMMENCING AS OF THE DATE OF APPROVAL</div>
    </div>
    <div style="text-align: center; line-height: 1.25;">(Item 4 on the Proxy Card)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The ICL requires Israeli companies with shares that have been offered to the public, to appoint at least two external directors. Our Board of Directors is currently composed of two
      external directors appointed in accordance with the ICL (Elyezer Shkedy and Amikam (Ami) Shafran).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our ESG and Nomination Committee&#160;believes that it is in the best interests of the Company to appoint an additional external director. Accordingly, it is proposed to appoint Hilla
      Haddad Chmelnik as an external director of the Company for a term of three years, commencing as of the date of approval by the Meeting, and our Board of Directors subsequently approved the recommendation of the ESG and Nomination Committee.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following information concerning Ms. Haddad Chmelnik is based on the records of the Company and information furnished to it by Ms. Haddad Chmelnik: </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-weight: bold; font-style: italic;">Hilla Haddad Chmelnik (41)</font><font style="font-style: italic;">&#160;</font>Ms. Haddad Chmelnik is a senior executive with
      extensive experience in the public and private sectors, specializing in strategic leadership of complex projects in the fields of innovation, transportation, and space technologies. Since May 2023, she has served as Co-Founder and Chief Strategy
      Officer of Moonshot, a startup developing an innovative electromagnetic launcher for raw materials and cargo to space. Ms. Haddad Chmelnik also led strategic and fundraising efforts at DOTS, an agri-tech company, and since August 2023 has served as
      an external director at NextGen Biomed Ltd. (TASE). From November 2021 to February 2023, Ms. Haddad Chmelnik served as the Director-General of the Israeli Ministry of Innovation, Science, and Technology. Prior to that, she held senior roles at Israel
      National Roads Company and the Ministry of Transport, including Vice President of Strategy and Innovation and Head of the National Infrastructure Directorate. Earlier in her career, she held key positions in Israel&#8217;s Ministry of Defense. Ms. Haddad
      Chmelnik holds a B.Sc. degree in Aerospace Engineering from the Technion, an M.A. in Diplomacy and an MBA from Tel Aviv University, and an M.A. in Public Policy from the Hebrew University of Jerusalem.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Subject to the approval of Ms. Haddad Chmelnik&#8217;s election at the Meeting, Ms. Haddad Chmelnik will benefit from D&amp;O indemnification and insurance under the same conditions as
      the other external directors and in accordance with the Company&#8217;s Compensation Policy. If elected, Ms. Haddad Chmelnik&#8217;s terms of compensation will be identical to the terms of the Company&#8217;s other external directors and in accordance with the
      Company&#8217;s Compensation Policy.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">Ms. Haddad has certified to the Company that she complies with all requirements under the ICL for serving as an external director.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: -36pt; margin-left: 72pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 4)</font>&#160;<font style="font-weight: bold;">RESOLVED</font>, approve of the election of Hilla Haddad Chmelnik as an external director, as
      defined in the ICL, including the approval of her compensation terms, for a three-year period commencing as of the date of approval.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Board of Directors recommends a vote <font style="font-weight: bold;">FOR</font> the election of Ms. Haddad Chmelnik as an external director, including the approval of her
      compensation terms, for a three-year period commencing as of the date of approval.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented and voting on this proposal in person or by proxy is necessary to grant options Ms.
      Haddad-Chmelnik.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, the shareholders&#8217; approval must either include at least a majority of the ordinary shares voted by shareholders who are not controlling shareholders nor are they
      shareholders who have a personal interest in her election as an external director (excluding a personal interest that is not related to a relationship with the controlling shareholder), or the total ordinary shares of non-controlling shareholders and
      non-interested shareholders voted against this proposal must not represent more than two percent of the outstanding ordinary shares.&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Relief Regulations, a shareholder submitting a vote for this Item is deemed to confirm to the Company that such shareholder does not have a personal interest
      in the approval of this Item (excluding a personal interest that is not related to a relationship with a controlling shareholder) and is not a controlling shareholder, unless such shareholder had delivered the Company a notice in writing stating
      otherwise, no later than 10:00 a.m., Israel time, on August 14, 2025, to the attention of the Company&#8217;s Corporate Secretary, at our registered office in Israel, 21 Yegia Kapayim St., Kiryat Arye, Petah Tikva 4913020, Israel.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">ITEM V.&#160;&#160; SUBJECT TO HER ELECTION PURSUANT TO ITEM NO. 4, TO APPROVE A</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"> GRANT OF OPTIONS TO HILLA HADDAD CHMELNIK, AS DESCRIBED IN THE PROXY STATEMENT</div>
      <div style="text-align: center; line-height: 1.25;">(Item 5 on the Proxy Card)</div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Under the ICL, any arrangement between the Company and a director relating to his or her compensation as a director or other position with the Company must be in compliance with
      the Company&#8217;s Compensation Policy for Executive Officers and Directors and requires approval of the Compensation Committee, the Board of Directors and the Company&#8217;s shareholders, in that order.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is proposed that, in addition to the cash compensation paid to our directors, to grant options to purchase ordinary shares of the Company to Hilla Haddad-Chmelnik.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Compensation Committee and Board of Directors approved and recommended granting its non-executive directors, including the Company&#8217;s external directors, upon their first
      appointment or appointment renewal (provided that there were no previously granted options at the grant date that remained unvested), options in the amount and under the conditions set and approved by the Compensation Committee, Board of Directors,
      and reaffirmed by the Company&#8217;s shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Compensation Committee and Board of Directors approved and recommended that our shareholders approve the grant of options to purchase 50,000 of our ordinary shares to Ms.
      Haddad-Chmelnik upon her election as an external director.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the terms of our 2008 Stock Options Plan and the Company&#8217;s Compensation Policy for Executive Officers and Directors, the exercise price of the options to be granted to
      Ms. Haddad Chmelnik will be 5% over the closing price of the Company&#8217;s ordinary shares on the NASDAQ Global Select Market on the grant date, which is the second trading day following Meeting (August 15, 2025).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Similar to previous grants of options to other Company directors, the options will vest and become exercisable quarterly over a three-year period, so long as the director continues
      to serve as a director and will be exercisable for 12 months following cessation or termination of his or her service (other than for cause).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 5)</font>&#160;<font style="font-weight: bold;">RESOLVED</font>, subject to her election under Item 4, to approve a grant of 50,000 options to
      Ms. Haddad Chmelnik, exercisable into ordinary shares of the Company as described in the Proxy Statement, upon her election as set forth in this Proxy Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented and voting on this proposal in person or by proxy is necessary to grant options Ms. Haddad
      Chmelnik.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, the shareholders&#8217; approval must either include at least a majority of the ordinary shares voted by shareholders who are not controlling shareholders nor are they
      shareholders who have a personal interest in the grant of the options to the external director (excluding a personal interest that is not related to a relationship with the controlling shareholder), or the total ordinary shares of non-controlling
      shareholders and non-interested shareholders voted against this proposal must not represent more than two percent of the outstanding ordinary shares.&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Relief Regulations, a shareholder submitting a vote for this Item is deemed to confirm to the Company that such shareholder does not have a personal interest
      in the approval of this Item (excluding a personal interest that is not related to a relationship with a controlling shareholder) and is not a controlling shareholder, unless such shareholder had delivered the Company a notice in writing stating
      otherwise, no later than 10:00 a.m., Israel time, on August 14, 2025, to the attention of the Company&#8217;s Corporate Secretary, at our registered office in Israel, 21 Yegia Kapayim St., Kiryat Arye, Petah Tikva 4913020, Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The Board of Directors recommends a vote <font style="font-weight: bold;">FOR</font> the grant of options Ms. Haddad Chmelnik the nominee for election as an external director.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ITEM VI. AMENDMENT TO THE COMPANY&#8217;S COMPENSATION POLICY FOR</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXECUTIVE OFFICERS AND DIRECTORS</div>
    <div style="text-align: center; line-height: 1.25;">(Item 6 on the Proxy Card)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the ICL, all Israeli public companies, including companies whose shares are publicly traded outside of Israel, such as the Company, are required to adopt a written
      compensation policy for their executive officers and directors, which addresses certain items prescribed by the ICL. In accordance with the ICL, the adoption, amendment, and restatement of the policy is to be recommended by the Compensation Committee
      and approved by the Board of Directors and shareholders, and such policy must be reviewed and readopted within three years from the previous adoption date. The Company&#8217;s Compensation Policy for Executive Officers and Directors (the &#8220;<font style="font-weight: bold;">Compensation Policy</font>&#8221;) was last reviewed and approved by the Compensation Committee, the Board of Directors, and our shareholders in May 2023.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;">The Compensation Policy allows for the reward of executives and directors with equity-based compensation, which supports the Company&#8217;s objective to align executive and
      directors&#8217; compensation with shareholder value and is consistent with the Company&#8217;s objective to increase shareholder value in the long term. The Compensation Policy further establishes that the Company may grant to executives and directors options
      or any other long-term equity-based compensation (&#8220;<font style="font-weight: bold;">Equity-based Compensation</font>&#8221;), pursuant to equity incentive plans as adopted or shall be adopted from time to time and subject to any applicable law.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Although the Compensation Policy allows for the grant of different types of equity-based compensation, the grant of Restricted Stock Units (&#8220;<font style="font-weight: bold;">RSUs</font>&#8221;),

      and Performance Stock Units (&#8220;<font style="font-weight: bold;">PSUs</font>&#8221;) may be frustrated due an ambiguity in the policy<font style="font-style: italic;">, </font>which the Company&#8217;s Board recommend to clarify and amend as follows (proposed
      additional language marked in <font style="font-weight: bold;"><u>bold underline</u></font>):</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-style: italic;">&#160;&#8220;&#8230;In case of grant of any Equity-based Compensation <font style="font-weight: bold;"><u>in the form of options</u></font>, the exercise price of such
      Equity-based Compensation shall not be less than 5% over the close price of the Company shares on NASDAQ in the last trading day prior to the grant date (or, in case that the Company&#8217; shares are not quoted on NASDAQ or such quote is otherwise
      unavailable, the exercise price shall not be less than 5% over the fair market value as will be determined by the Company)&#8230;&#8221;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">As by their nature RSUs and PSUs do not have an exercise/purchase price beyond the nominal par value attributed to the issuance of the underlying shares upon vesting, whereas
      options are granted with an exercise price that is equal to, or with a premium, to market price, by adding the underlined bold text, the ambiguity in the Compensation Policy<font style="font-style: italic;">&#160;</font>will be clarified and amended. The
      Compensation Committee and the Board of Directors recommend amending the Compensation Policy as set forth above. The complete Compensation Policy is attached hereto as <font style="font-weight: bold; font-style: italic;">Annex A</font>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.45pt; line-height: 1.25;"><font style="font-style: italic;">(Item 6)</font>&#160;<font style="font-weight: bold;">RESOLVED</font>, to amend and readopt the Company&#8217;s Compensation Policy for Executive Officers
      and Directors as set forth in Item 6 and in&#160;<font style="font-weight: bold; font-style: italic;">Annex A </font>of this Proxy Statement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented and voting on this proposal in person or by proxy is necessary to amend the&#160;Compensation Policy
      for Executive Officers and Directors.&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In addition, the shareholders&#8217; approval must either include at least a majority of the ordinary shares voted by shareholders who are not controlling shareholders nor are they
      shareholders who have a personal interest in the amendment to the&#160;Compensation Policy for Executive Officers and Directors (excluding a personal interest that is not related to a relationship with the controlling shareholder), or the total ordinary
      shares of non-controlling shareholders and non-interested shareholders voted against this proposal must not represent more than two percent of the outstanding ordinary shares. For this purpose, you are asked to indicate on the enclosed proxy card
      whether you are a controlling shareholder or have a personal interest in the amendment to the&#160;Compensation Policy for Executive Officers and Directors&#160;(excluding a personal interest that is not related to a relationship with a controlling
      shareholder).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Relief Regulations, a shareholder submitting a vote for this Item is deemed to confirm to the Company that such shareholder does not have a personal interest
      in the approval of this Item (excluding a personal interest that is not related to a relationship with a controlling shareholder) and is not a controlling shareholder, unless such shareholder had delivered the Company a notice in writing stating
      otherwise, no later than 10 a.m., Israel time, on August 14, 2025, to the attention of the Company&#8217;s Corporate Secretary, at our registered office in Israel, 21 Yegia Kapayim St., Kiryat Arye, Petah Tikva 4913020, Israel.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The&#160;Board of Directors recommends a vote <font style="font-weight: bold;">FOR </font>the amendment and re-adoption of the Compensation Policy for Executive Officers and
      Directors.<br>
      <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ITEM VII. TO APPROVE A GRANT OF PERFORMANCE STOCK UNITS TO MR. ADI</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> SFADIA, THE COMPANY&#8217;S CHIEF EXECUTIVE OFFICER</div>
    <div style="text-align: center; line-height: 1.25;">(Item 7 on the Proxy Card)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the ICL, any arrangement between the Company and its Chief Executive Officer relating to his or her compensation must generally be in compliance with the Company&#8217;s
      Compensation Policy for Executive Officers and Directors and requires approval of the Compensation Committee, the Board of Directors and the Company&#8217;s shareholders, in that order.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Adi Sfadia has served as our Chief Executive Officer since November 2020, after serving as our interim Chief Executive Officer from July 2020.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our Compensation Committee and Board of Directors approved on February 10, 2025 and February 11, 2025, respectively, and recommended that our shareholders approve, the grant to&#160;Mr.
      Sfadia of an aggregate of 180,000 Performance Stock Units (&#8220;<font style="font-weight: bold;">PSUs</font>&#8221;), with (i) 150,000 of the PSUs vesting in four (4) equal annual instalments of twenty-five percent (25%) each, starting on the first anniversary
      of the grant date, subject to compliance with share price and Volume Weighted Average Price (VWAP) thresholds set by the Compensation Committee and the Board, and (ii) 30,000 of the PSUs vesting in four (4) equal annual instalments of twenty-five
      percent (25%) each, starting on the first anniversary of the grant date, subject to compliance with an Adjusted EBITDA threshold for the year 2025 of USD 53 million.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">No changes are recommended to be made to Mr. Sfadia&#8217;s monthly salary or annual bonus target previously approved by the Company&#8217;s shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 7) </font><font style="font-weight: bold;">RESOLVED</font>, subject to the approval of the amendment to the Company&#8217;s Compensation Policy
      as set forth under Item 6, to approve a grant of PSUs to Mr. Adi Sfadia, the Company&#8217;s Chief Executive Officer, as outlined in Item 7 of this Proxy Statement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The approval of the resolution in this Item 7 requires&#160;the affirmative vote of a majority of the shares present, in person or by proxy, and voting on the matter, provided that
      either: (i) at least a majority of the shares of shareholders who are not controlling shareholders and do not have a personal interest in the resolution are voted in favor of the proposed resolution; or (ii) the total number of shares of shareholders
      who are not controlling shareholders and do not have a personal interest in the resolution and are voted against the proposed resolution does not exceed two percent of the outstanding voting power in the Company.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Relief Regulations, a shareholder submitting a vote for this Item 7 is deemed to confirm to the Company that such shareholder does not have a personal
        interest in the approval of the compensation of the Chief Executive Officer and is not a controlling shareholder, unless such shareholder had delivered the Company a notice in writing stating otherwise, no later than 10 a.m., Israel time, on August
        14, 2025, to the attention of the Company&#8217;s Corporate Secretary, at our registered office in Israel, 21 Yegia Kapayim St., Kiryat Arye, Petah Tikva 4913020, Israel.</div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The&#160;Board of Directors recommends a vote <font style="font-weight: bold;">FOR </font>the approval of the grant of PSUs to the Company&#8217;s Chief Executive Officer.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ITEM VIII.&#160; RATIFICATION AND APPROVAL OF REAPPOINTMENT AND <br>
      COMPENSATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS</div>
    <div style="text-align: center; line-height: 1.25;">(Item 8 on the Proxy Card)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Kost Forer Gabbay &amp; Kasierer, our independent registered public accountants, and a Member of Ernst &amp; Young Global, have been our independent registered public accountants
      since 2000. It is proposed that at the Meeting, the Company&#8217;s shareholders will ratify and approve the re-appointment of Kost Forer Gabbay &amp; Kasierer as our independent registered public accountants for the fiscal year ending December 31, 2024,
      and for such additional period until the next annual general meeting of shareholders. In light of the familiarity of Kost Forer Gabbay &amp; Kasierer with our operations and their reputation in the auditing field, our Audit Committee and Board of
      Directors believe that the firm has the necessary personnel, professional qualifications and independence to act as our independent registered public accountants.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The following table sets forth the fees we paid to Kost Forer Gabbay &amp; Kasierer with respect to fiscal year 2024:</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="2" border="0" align="center" id="z6a98eef9e12b412c817e594eeff3d8d3" style="width: 85%; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left;">

        <tr>
          <td style="width: 36.84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Services Rendered</div>
          </td>
          <td style="width: 36.85%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Fees</div>
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(in thousands)</div>
          </td>
          <td style="width: 26.31%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Percentage</div>
          </td>
        </tr>
        <tr>
          <td style="width: 36.84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Audit fees <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
          <td style="width: 36.85%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$770</div>
          </td>
          <td style="width: 26.31%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">55%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 36.84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Tax fees <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
          </td>
          <td style="width: 36.85%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$159</div>
          </td>
          <td style="width: 26.31%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">12%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 36.84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Other <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
          </td>
          <td style="width: 36.85%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$463</div>
          </td>
          <td style="width: 26.31%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">44%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 36.84%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Total</div>
          </td>
          <td style="width: 36.85%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">$1,392</div>
          </td>
          <td style="width: 26.31%; vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">100%</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z5087c9a52c4d43d4a5817aebbb485b6c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.65pt;"><br>
          </td>
          <td style="width: 21.25pt; vertical-align: top;">(1)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Audit fees include fees associated with the annual audit, services provided in connection with the audit of our internal control over financial reporting and audit services provided in connection with other statutory or regulatory filings.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zd2d645792020413a87da149d4dbfc7b0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.65pt;"><br>
          </td>
          <td style="width: 21.25pt; vertical-align: top;">(2)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Tax fees are fees for professional services rendered by our auditors for tax compliance, tax planning and tax advice on actual or contemplated transactions.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zd90cebd891a3469385374edcdcf0da80" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49.65pt;"><br>
          </td>
          <td style="width: 22.35pt; vertical-align: top;">(3)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Other fees are fees for professional services other than audit or tax related fees.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">In accordance with the Company&#8217;s procedures, our Audit Committee has approved all audit and non-audit services provided by Kost Forer Gabbay &amp; Kasierer to the Company and to
      its subsidiaries during 2024.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">It is therefore proposed that at the Meeting the following resolution be adopted:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">(Item 8)</font>&#160;<font style="font-weight: bold;">RESOLVED</font>, that the appointment of Kost Forer Gabbay &amp; Kasierer, a member of Ernst
      &amp; Young Global, as the Company&#8217;s independent public accountants for the fiscal year ending December 31, 2025 and for such additional period until the next annual general meeting of shareholders, be, and it hereby is, ratified, and the Board of
      Directors (or, the Audit Committee, if authorized by the Board of Directors (subject to the ratification of the Board of Directors) be, and it hereby is, authorized to fix the remuneration of such independent public accountants in accordance with the
      volume and nature of their services.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the ordinary shares represented at the Meeting, in person or by proxy, entitled to vote and voting on the matter, is required
      to approve the foregoing resolution.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">The&#160;Board of Directors recommends a vote <font style="font-weight: bold;">FOR</font> the ratification and approval of reappointment and compensation of independent registered
      public accountants.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; text-indent: -36pt; margin-right: 36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;">CONSIDERATION OF THE AUDITOR&#8217;S REPORT AND THE CONSOLIDATED</div>
    <div style="text-align: center; text-indent: -36pt; margin-right: 36pt; margin-left: 36pt; line-height: 1.25; font-weight: bold;"> FINANCIAL STATEMENTS</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">At the Meeting, our consolidated financial statements for the year ended December 31, 2024 and the Auditor&#8217;s Report in respect thereto will be presented and considered. This item
      will not involve a vote of the shareholders.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Our 2024 Consolidated Financial Statements are published as part of our Annual Report on Form 20-F for the year ended December 31, 2024, and can be viewed on our website at <u>www.gilat.com</u>
      and on the SEC website at&#160;<u>www.sec.gov</u>. A shareholder interested in receiving a copy free of charge may contact the Company&#8217;s Chief Financial Officer for such purpose. None of the auditor&#8217;s report, consolidated financial statements, the Form
      20-F or the contents of our website form part of the proxy solicitation material.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ADDITIONAL INFORMATION</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 39.6pt; margin-left: 1.1pt; line-height: 1.25;">The following table sets forth certain information regarding the beneficial ownership of our ordinary shares, as of July 7, 2025, by:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z5200e6e1d2d840fe8e4979debf3682de" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 58.7pt;"><br>
          </td>
          <td style="width: 12.2pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>each person who we believe beneficially owns 5% or more of our outstanding ordinary shares, and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="za4da360e6eb040e0aa63ba515d139251" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 58.7pt;"><br>
          </td>
          <td style="width: 12.2pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>all of our directors and executive officers as a group.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 39.6pt; margin-left: 1.1pt; line-height: 1.25;">Beneficial ownership of shares is determined under rules of the U.S. Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;)
      and generally includes any shares over which a person exercises sole or shared voting or investment power.&#160;The percentage ownership of each such person is based on the number of ordinary Shares outstanding as of July 7, 2025 and includes the number
      of ordinary shares underlying options that are exercisable within sixty (60) days from the date of July 7, 2025.&#160;Ordinary shares subject to these options are deemed to be outstanding for the purpose of computing the ownership percentage of the person
      holding these options but are not deemed to be outstanding for the purpose of computing the ownership percentage of any other person. The information in the table below is based on 57,211,899&#160; ordinary shares outstanding as of July 7, 2025. Each of
      our outstanding ordinary shares has identical rights in all respects. The information in the table below with respect to the beneficial ownership of shareholders is based on the public filings of such shareholders with the SEC through July 7, 2025
      and information provided to us by such shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" style="width: 85%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;" id="zd7213e6233d8457188f50d9ed3a677c0" class="cfttable">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25;">
              <div style="line-height: 1.25;">Name</div>
            </div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">Number of Shares</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="line-height: 1.25;">
              <div style="text-align: center; line-height: 1.25;">Percent</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;"> </font></div>
            </div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Phoenix Holdings Ltd.&#160; <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">10,584,499</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255);" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">18.56</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255);" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: bottom; width: 76%;">
            <div style="line-height: 1.25;">All directors and executive officers as a group (16 persons) <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">2,232,500</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
            <div style="line-height: 1.25;">3.90</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
            <div style="line-height: 1.25;">%</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: -21.25pt; margin-left: 56.7pt; line-height: 1.25;">____________________________________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zed039099cb5940b9b74e9d52d6870a58" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 32.2pt;"><br>
          </td>
          <td style="width: 39.8pt; vertical-align: top;">(1)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Based on Schedule 13D filed on February 10, 2025 with the SEC by Phoenix Holdings Ltd. and information provided to us by Phoenix Holdings as of December 31, 2024. The ordinary shares reported are beneficially owned by various direct or
              indirect, majority or wholly owned subsidiaries of Benelus Lux S.a.r.l and/or Phoenix Holdings Ltd. and/or Excellence Investments Ltd. The Subsidiaries manage their own funds and/or the funds of others, including for holders of
              exchange-traded notes or various insurance policies, members of pension or provident funds, unit holders of mutual funds, and portfolio management clients. CP III Cayman GP Ltd., Matthew Botein and Lewis (Lee) Sachs are the controlling
              shareholders of Benelus Lux S.a.r.l. The principal office of Phoenix Holdings Ltd. is 53 Derech Hashalom Drive, Ramat Gan 5345433.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z0b5a6de292254718990c13edbceafa3b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 32.2pt;"><br>
          </td>
          <td style="width: 39.8pt; vertical-align: top;">(2)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>As of July 7, 2025, all directors and executive officers as a group (16 persons) held 1,526,667 options that are vested or that vest within 60 days of July 7, 2025.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 36pt; line-height: 1.25; font-weight: bold;">Shareholder Communications with the Board of Directors</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; line-height: 1.25;">Our shareholders may communicate with the members of our Board of Directors by writing directly to the Board of Directors or to specified individual Directors
      to the attention of:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">Doron Kerbel, General Counsel &amp; Corporate Secretary</div>
    <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">Gilat Satellite Networks Ltd.</div>
    <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">21 Yegia Kapayim Street</div>
    <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">Kiryat Arye</div>
    <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">Petah Tikva 4913020 Israel</div>
    <div style="text-align: justify; text-indent: 72pt; margin-right: 36pt; line-height: 1.25;">Email: <u>doronke@gilat.com</u></div>
    <div style="text-align: justify; margin-right: 36pt; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; line-height: 1.25;">Our Corporate Secretary will deliver any shareholder communications to the specified individual Director, if so addressed, or otherwise to one of our Directors
      who can address the matter.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 36pt; line-height: 1.25; font-weight: bold;">Shareholder Proposals for 2026 Annual General Meeting of Shareholders</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; margin-right: 0.2pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Under the ICL, shareholders who severally or jointly hold at least 1% of our outstanding voting rights are entitled to request that the Board of Directors include a
      proposal in a future shareholders meeting, provided that such proposal is appropriate for consideration by shareholders at such meeting; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that if
      the matter requested to be added to the agenda is to appoint or remove a director, such request must be submitted by one or more shareholders holding at least 5% of the voting rights at a general meeting of shareholders. To be considered for
      inclusion in our proxy statement for our 2026 annual general meeting of shareholders pursuant to the ICL, shareholder proposals must be in writing and must be properly submitted to 21 Yegia Kapayim Street, Kiryat Arye, Petah Tikva 4913020 Israel,
      Attention: Corporate Secretary, and must otherwise comply with the requirements of the ICL. The written proposal must be received by Gilat not less than 90 calendar days prior to the first anniversary of the 2025 Annual General Meeting of
      Shareholders (i.e., no later than May 14, 2026); provided that if the date of the 2026 annual general meeting of shareholders is advanced by more than 30 calendar days prior to, or delayed (other than as a result of adjournment) by more than 30
      calendar days after, the anniversary of the 2025 Annual General Meeting of Shareholders, for a proposal by a shareholder to be timely it must be so delivered not later than the 7th calendar day following the day on which we call and provide notice of
      the 2026 annual general meeting of shareholders.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; line-height: 1.25;">We currently expect that the agenda for our annual general meeting of shareholders to be held in 2026&#160;will include (1) the election (or reelection) of
      directors including one external director; (2) the approval of the appointment (or reappointment) of the Company&#8217;s auditors; and (3) presentation and discussion of the financial statements of the Company for the year ended December 31, 2025 and the
      auditors&#8217; report for this period. In general, a shareholder proposal must be in English and must set forth (i) the name, business address, telephone number, fax number and email address of the proposing shareholder (and each member of the group
      constituting the proposing shareholder, if applicable) and, if not a natural person, the same information with respect to the person(s) that controls or manages such person, (ii) the number of ordinary shares held by the proposing shareholder,
      directly or indirectly, including if beneficially owned by the proposing shareholder (within the meaning of Rule 13d-3 promulgated under the United States Securities Exchange Act of 1934, as amended); if any of such ordinary shares are held
      indirectly, an explanation of how they are held and by whom, and, if such proposing shareholder is not the holder of record of any such ordinary shares, a written statement from an authorized bank, broker, depository or other nominee, as the case may
      be, indicating the number of ordinary shares the proposing shareholder is entitled to vote as of a date that is no more than ten (10) days prior to the date of delivery of the shareholder proposal, (iii) any agreements, arrangements, understandings
      or relationships between the proposing shareholder and any other person with respect to any securities of the Company or the subject matter of the shareholder proposal, including any derivative, swap or other transaction or series of transactions
      engaged in, directly or indirectly, by such proposing shareholder, the purpose or effect of which is to give such proposing shareholder economic risk similar to ownership of shares of any class or series of the company, (iv) the proposing
      shareholder&#8217;s purpose in making the proposal, (v) the complete text of the resolution that the proposing shareholder proposes to be voted upon at the 2026 annual general meeting of shareholders, (vi) a statement of whether the proposing shareholder
      has a personal interest in the proposal and, if so, a description in reasonable detail of such personal interest, (vii) a declaration that all the information that is required under the ICL and any other applicable law to be provided to the company
      in connection with such subject, if any, has been provided, (viii) if the proposal is to nominate a candidate for election to the board of directors, a questionnaire and declaration, in form and substance reasonably requested by the company, signed
      by the nominee with respect to matters relating to his or her identity, address, background, credentials, expertise, etc., and his or her consent to be named as a candidate and, if elected, to serve on the board of directors, and (ix) any other
      information reasonably requested by the company. We shall be entitled to publish information provided by a proposing shareholder, and the proposing shareholder shall be responsible for the accuracy thereof. In addition, shareholder proposals must
      otherwise comply with applicable law and our Articles of Association. The company may disregard shareholder proposals that are not timely and validly submitted.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; line-height: 1.25;">The information set forth in this section is, and should be construed, as a &#8220;pre-announcement notice&#8221; of the 2026 annual general meeting of shareholders in
      accordance with Rule 5C of Israel&#8217;s Companies Regulations (Notice of General and Class Meetings in a Public Company), 2000, as amended.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Annex A</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Compensation Policy</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">for Executive Officers Gilat Satellite Networks Ltd.</div>
    <div style="text-align: center; margin-right: 147.4pt; margin-left: 138.25pt; line-height: 1.25; font-weight: bold;">(the &#8220;Company&#8221;)</div>
    <table cellspacing="0" cellpadding="0" id="z1495cd751f194186a285d760922a9364" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 24.95pt;"><br>
          </td>
          <td style="width: 18.05pt; vertical-align: top; font-weight: bold;">A.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Overview and Objectives</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z327b0df07dc54d48ac1126bd45a1fc6b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 18.05pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Introduction</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">Pursuant to the provisions of the Companies Law 5759&#8211;1999 (the &#8220;<font style="font-weight: bold;">Companies Law</font>&#8221;), This document
      sets forth the compensation policy for Executive Officers (as defined below) (the &#8220;<font style="font-weight: bold;">Executive Compensation Policy</font>&#8221; or &#8220;<font style="font-weight: bold;">Policy</font>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.65pt; margin-left: 7pt; line-height: 1.25;">This Executive Compensation Policy shall apply to terms of service and compensation of Executive Officers which will be approved for
      payment after the date on which this Executive Compensation Policy was approved by the shareholders of the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">The term &#8220;Executive Officer&#8221; or &#8220;Executive&#8221; in this policy is defined as: &#8220;a chief executive officer, a chief business manager, a deputy
      general manager, vice general manager, any person who holds such position in the company even if such person holds a different title, and Chairman of the Board or a Directors or a manager who reports directly to the chief executive officer&#8221;.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.1pt; margin-left: 7pt; line-height: 1.25;">This Policy is subject to all mandatory provisions of any applicable law which apply to the Company and its Executives, and to the
      Company&#8217;s Articles of Association.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zafd26fb01e144dbd8b9a65824f8653dc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 18.05pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Objectives and Compensation Principles</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">The objectives and goals which are the basis of this Policy are to allow the Company to attract and retain highly skilled and experienced
      personnel who will serve as Executive Officers in key positions in the Company, with the ultimate objective to maintain the Company&#8217;s leadership and success and enhance shareholder value. Accordingly, this Policy is designed, among other things, to
      provide the Executives with a competitive compensation package which includes performance-based compensation that differentiates between Executives and rewards excellence, and to align the interests of the Executives with those of the Company&#8217;s
      shareholders.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 38.15pt; margin-right: 15.65pt; margin-left: 7pt; line-height: 1.25;">In determining the compensation terms for Executives (including, without limitation, terms of retirement or termination) and any change
      thereof, the Compensation Committee and Board of Directors of the Company (the &#8220;<font style="font-weight: bold;">Board</font>&#8221; or &#8220;<font style="font-weight: bold;">Board of Directors</font>&#8221;) shall take into account, among other things, the
      following: (i) the education, qualifications, expertise, skills, professional experience, achievements and seniority of the Executive; (ii) the role of the Executive, areas and degree of responsibility, his or her past or expected contribution to the
      Company, anticipated promotion of the Executive within the Company and, if available, past compensation agreements signed with him or her and the circumstances of his or her recruitment; (iii) the size of the Company and its nature as a global
      company and the complexity of the Company&#8217;s business; and (iv) comparison to compensation payable to Executives at comparable companies as more fully set forth in section B.1. below.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">Additionally, in the process of determining the compensation terms for each Executive, the Company shall examine the ratio between the
      overall compensation and base salary of the Executive, on the one hand, and the average and median salary (as such term is defined in the Companies Law), as well as the average and median overall compensation, of the other employees of the Company
      (including personnel of services companies and excluding the Executives and Directors) (the &#8220;<font style="font-weight: bold;">Other Employees</font>&#8221;), on the other hand. The Company will consider the impact that such ratios are expected to have on
      the work environment in order to ensure that such ratios are not expected to have any negative impact on the working relationships within the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.05pt; margin-left: 7pt; line-height: 1.25;">In approving this Policy, the Board has examined the ratio between the average cost of the overall compensation payable to Executives,
      on the one hand, and the average and median cost of the overall compensation payable to the Other Employees, on the other hand.</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.05pt; margin-left: 7pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%A - %%-->
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z1a3d725984034d14b5d3a24e9a97d5e5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 24.95pt;"><br>
          </td>
          <td style="width: 18.05pt; vertical-align: top; font-weight: bold;">B.</td>
          <td style="width: auto; vertical-align: top;">
            <div style="font-weight: bold;"><u>Compensation Structure</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.05pt; margin-left: 7pt; line-height: 1.25;">The Executives&#8217; compensation package may include: base salary, fringe benefits, cash bonuses, equity-based compensation, separation
      arrangements and Insurance, Exculpation and Indemnification.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z4c1343fccf5345b28a184d89ae132877" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Base Salary</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.05pt; margin-left: 7pt; line-height: 1.25;">The base salary or monthly fees of each Executive in the Company shall be determined based on the parameters specified in Section A.2
      above, including the Company&#8217;s need to attract and retain highly skilled executives and offer them competitive terms, while considering the Company&#8217;s size and nature.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">Prior to approval of a compensation package for an Executive, the Company will consider a compensation survey that compares and analyzes
      the level of the compensation offered to the Executive with compensation packages for similarly positioned executives in peer-group companies. The survey will be conducted with respect to executives at comparable positions at the headquarters of
      publicly traded, high-technology companies with comparable headcount, and will be based on reports of a known compensation and benefits surveys company or by an external expert.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.95pt; margin-left: 7pt; line-height: 1.25;">The base salary will not be linked to the consumer price index (but will be linked to an increase in the cost of living index as
      mandatory by applicable law).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.85pt; margin-left: 7pt; line-height: 1.25;">The base salary for Executives is reviewed and may be adjusted from time to time by the Compensation Committee and the Board of
      Directors and if applicable under the Companies Law, subject to approval of the General Meeting of shareholders or as otherwise required by applicable law, based on the guidelines detailed in Section A.2 above.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">In any event, the base salary of the CEO and of the Chairman of the Board shall not exceed NIS 130,000 per month, and the base salary of
      any Executive in the Company (other than the CEO and Chairman of the Board) shall not exceed NIS 90,000 per month.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">For purpose of attracting highly skilled executives, the Company may offer an Executive a one- time sign-on bonus as an incentive to join
      the Company. The amount of the sign-on bonus shall not exceed the Executive&#8217;s base salary or monthly fees for six (6) months. Entitlement to such bonus shall be subject to a minimum period of employment of the Executive with the Company as shall be
      determined by the Company, but in any event of not less than twelve (12) months.</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z1d92c0d1f5e54cb2979e69d26a470838" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Executive&#8217;s Fringe Benefits</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">The compensation package will include any payments and rights due to the Executive under applicable law, and may include additional
      benefits including social benefits, company mobile telephone, reimbursement of expenses, vacation days, medical insurance, and additional benefits which are granted in general to the Company&#8217;s employees.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.55pt; margin-left: 7pt; line-height: 1.25;">The Company shall maintain and contribute to an executive insurance program and/or pension programs for the Executive, as allowed by
      applicable law. Additionally, the Company shall contribute for the executive towards disability insurance as allowed by applicable law. The Company shall contribute monthly payments for a study fund, as allowed by applicable law. All such payments
      may be calculated based on part of or the entire monthly base salary of the Executive.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">Executives shall be entitled to vacation in the range of 18 to 26 days per year of employment. The Company shall reimburse Executives for
      their business expenses that are properly documented and approved in accordance with the Company&#8217;s expenses reimbursement policy. The Executive may join the Company&#8217;s car leasing program generally available to the Company&#8217;s employees, at the
      Executive&#8217;s expense.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.05pt; margin-left: 7pt; line-height: 1.25;">The Company may offer additional benefits to the Executive, which will be comparable to customary market practices and which will not
      exceed 4% of the Executive&#8217;s annual base salary.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.85pt; margin-left: 7pt; line-height: 1.25;">Any non-Israeli Executives may receive other similar, comparable or customary benefits as applicable in the relevant jurisdiction in
      which they are employed.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">In the event that an Executive provides services to the Company as a contractor or via a services company, the fees paid to such
      Executive or company shall reflect the employer&#8217;s cost of the base salary and fringe benefits (plus applicable taxes such as value added tax), in accordance with the guidelines of this Policy.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5413c0245cc043c9a2c5de0038f18984" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Cash Bonuses</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z095e530a63ad471a9a2810593c0d7bbc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.35pt;"><br>
          </td>
          <td style="width: 36.65pt; vertical-align: top;">3.1</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Cash Bonuses</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.9pt; margin-left: 7pt; line-height: 1.25;">Rewarding Executives based on performance supports the Company&#8217;s objective to link the Executive&#8217;s Compensation and financial interests
      with the Company&#8217;s results and shareholders&#8217; value, as set forth in section A.2 above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">The compensation package of Executives may include an annual cash bonus (the &#8220;<font style="font-weight: bold;">Annual Bonus</font>&#8221;).
      Additionally, the Company may determine that an Executive shall be entitled to a special bonus, considering the exceptional contribution of such Executive to the Company (for example, with respect to a special project) (&#8220;<font style="font-weight: bold;">Special Bonus</font>&#8221;).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">Payment of the Annual Bonus to any Executive, shall be conditioned upon the cumulative following conditions:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.1pt; margin-left: 7pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;achievement of a minimum positive Profitability Metric as determined by the Company; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.1pt; margin-left: 7pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; meeting a threshold of not less than 80% of the Profitability Metric target, as set out in the annual budget approved by the
      Board.</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 16.1pt; margin-left: 7pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">&#8220;Profitability Metric&#8221; means either operating profit, net profit or EBITDA as will be determined by the Compensation Committee and the
      Board of Directors at the beginning of each year.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.95pt; margin-left: 7pt; line-height: 1.25;">The Board of Directors may approve grant of a partial bonus in an amount of up to three (3) Base Salaries in cases where the
      abovementioned conditions have not been met, if the Board of Directors finds it appropriate to reward the executive officer for his/her efforts and professional skills regardless of achievement of the above mentioned conditions.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.85pt; margin-left: 7pt; line-height: 1.25;">The Annual Bonus will be based mostly on measurable pre-determined targets at certain weights, and, with respect to its less significant
      part based on non-measurable qualitative goals.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 42.4pt; line-height: 1.25;">Measurable targets for the cash bonuses may include, among others, any of the following:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z9ebe2083de51485fa198c88d2d7aabe9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.25pt;"><br>
          </td>
          <td style="width: 36.75pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>financial targets, such as the Company&#8217;s profit (EBITDA or other financial component), the EBITDA of a relevant division of the Company or certain project(s), revenues of the Company or of a certain division, cash flow targets of the
              Company, and other financial targets based on budget or work plan;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z09e99fbd2bc3434394a1eb7a3a846aa6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.35pt;"><br>
          </td>
          <td style="width: 36.65pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>sales results;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z43ddaa0f6efa42cc8194d7932d7cfb7d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.4pt;"><br>
          </td>
          <td style="width: 36.6pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>meeting measurable milestones as relevant for each Executive, for example, obtaining new business at a certain financial scope or signing agreements with a certain number of new customers;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z0c9b07ed77be438bb7696c4b8f9894f2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.35pt;"><br>
          </td>
          <td style="width: 36.65pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>execution of projects;</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z8c6633336dbb489890dd4cdcf787cf0f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.35pt;"><br>
          </td>
          <td style="width: 36.65pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>innovation defined by specific milestones (for example, registration of patents);</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zc3c9d6365b6c43d98110f457075341e0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.35pt;"><br>
          </td>
          <td style="width: 36.65pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>raising capital and closing financing transactions; and</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z8f043c6359364f038aebd3c5ed7c64e4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.35pt;"><br>
          </td>
          <td style="width: 36.65pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top;">
            <div>meeting market share targets.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.6pt; margin-left: 7pt; line-height: 1.25;">Qualitative targets for the Annual Bonus may include, among others, the general contribution of the Executive to the Company,
      satisfaction with the Executive&#8217;s performance, the Executive&#8217;s contribution to units other than the unit in which Executive is employed and to the ethical environment within the Company, the Executive&#8217;s contribution to development of skill of
      personnel reporting to Executive, or any other qualitative target determined by the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.6pt; margin-left: 7pt; line-height: 1.25;">In the event of a Change in Control of the Company (as defined below) during a bonus year or during a bonus deferral period, the Deferred
      Amount shall become payable at the time of payment of the Annual Bonus or the time the acquisition is consummated, as applicable. A &#8220;Change in Control&#8221; shall mean a merger, consolidation or other reorganization approved by the Company's shareholders,
      unless securities representing more than fifty percent (50%) of the total combined voting power of the voting securities of the successor company are immediately thereafter beneficially owned, directly or indirectly and in substantially the same
      proportion, by the persons who beneficially owned the Company's outstanding voting securities immediately prior to such transaction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zec7ed6d8b10047a085cb6b73511e58c2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">3.2.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Maximum Amount of Cash Bonuses</u></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 38.75pt; margin-right: 16.149pt; margin-left: 7pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; text-indent: 38.75pt; margin-right: 16.149pt; margin-left: 7pt; line-height: 1.25;">The aggregate amount of the Annual Bonuses to be granted to all of the Executives with respect to a specific fiscal year shall not
      exceed 15% of the operating profit for such year.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 38.75pt; margin-right: 16.149pt; margin-left: 7pt; line-height: 1.25;">The Compensation Committee and the Board of Director may approve a grant of a Special Bonus to be paid to an Executive, including the
      CEO, which shall not exceed the base salaries of such Executive for three (3) months.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 38.75pt; margin-right: 16.149pt; margin-left: 7pt; line-height: 1.25;">The aggregate amount of the Annual Bonus and the Special Bonus to be paid to an Executive reporting to the CEO for any year shall not
      exceed such Executive&#8217;s base salary or monthly fees for eight (8) months.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 38.75pt; margin-right: 16.149pt; margin-left: 7pt; line-height: 1.25;">The aggregate amount of the Annual Bonus and the Special Bonus to be paid to the CEO or the Chairman of the Board for any year shall
      not exceed the CEO&#8217;s or the Chairman of the Board&#8217;s, as the case may be, respective base salary or monthly fees for twelve (12) months.</div>
    <div style="text-align: justify; text-indent: 38.75pt; margin-right: 16.149pt; margin-left: 7pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 4</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z506ca4991b5c471e85357d02a0a9c090" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 45.7pt;"><br>
          </td>
          <td style="width: 33.3pt; vertical-align: top;">3.3.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Board Discretion</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">The Board of Directors shall have the discretion to reduce the amount of the Annual Bonus and/or the Special Bonus to be awarded to
      Executives by up to 20% of the amount due to an Executive prior to such decrease, if the Board of Directors determines that such a decrease is advisable due to unusual adverse circumstances, such as, without limitation, a material decline in the
      Company&#8217;s financial and operational performance.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z74f067b8e2434989b3a64eeac157a458" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">3.4.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Claw Back</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.6pt; margin-left: 7pt; line-height: 1.25;">Executives shall be required to repay to the Company any excess payments made to them which were based on the Company&#8217;s performance if
      such payments were paid on the basis of data in the Company&#8217;s financial statements which was later discovered to be inaccurate and such financials were subsequently restated. The repayment obligation shall apply only if the restatement was made
      within the 3- year period following payment to the Executive. The Executives shall be required to repay such amounts following a written notice by the Board specifying the grounds for such repayment. In such event, the Board shall specify the time
      frames and other terms of such repayment (e.g. whether repayment will be made net of taxes).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z0d3679c365014be58e4bbed0a8409bc3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Equity-based Compensation</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.75pt; margin-left: 7pt; line-height: 1.25;">Rewarding Executives with equity-based compensation supports the Company&#8217;s objective to align Executive Compensation with shareholder
      value, as set forth in section A.2 above and is consistent with the Company&#8217;s objective to increase shareholder value in the long term.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.75pt; margin-left: 7pt; line-height: 1.25;">The Company may grant to Executives options or any other long-term equity-based compensation (&#8220;<font style="font-weight: bold;">Equity-based

        Compensation</font>&#8221;), pursuant to equity incentive plans as adopted or shall be adopted from time to time and subject to any applicable law.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 43pt; line-height: 1.25;">Equity-Based Compensation granted to Executives shall vest over a period of at least 3 years.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">The value of the Equity-Based Compensation granted to an Executive other than the CEO and the Chairman of the Board (determined based on
      generally accepted accounting principles applicable to the Company) vesting in a calendar year (calculated on a linear basis) shall not exceed at the time of grant the amount equal to the base salary of the Executive for eight (8) months. Such value
      of the Equity-Based Compensation granted to the CEO or the Chairman of the Board, as the case may be, vesting in a calendar year as aforementioned shall not exceed his or her respective base salary or monthly fees for twelve (12) months.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">The Compensation Committee and the Board also considered setting a cap on the value for Equity- Based Compensation at the time of
      exercise and concluded that this would not be advisable considering, among other things, the limit on value at the date of grant as specified above.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.95pt; margin-left: 7pt; line-height: 1.25;">Equity-Based Compensation will generally expire 90 days following termination of Executive&#8217;s employment or service with the Company,
      other than in certain circumstances defined in the equity incentive plans. The Company may, in certain exceptional circumstances, extend the period to exercise Equity-based Compensation beyond such period for a period of up to twelve (12) months.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">In case of grant of any Equity-based Compensation <font style="font-weight: bold; font-style: italic;"><u>in the form of options</u></font>,
      the exercise price of such Equity-based Compensation shall not be less than 5% over the close price of the Company shares on NASDAQ in the last trading day prior to the grant date (or, in case that the Company&#8217; shares are not quoted on NASDAQ or such
      quote is otherwise unavailable, the exercise price shall not be less than 5% over the fair market value as will be determined by the Company).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.75pt; margin-left: 7pt; line-height: 1.25;">The Company may approve acceleration of the vesting period of any Equity-Based Compensation in connection with a transaction involving a
      change of control in the Company.</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.75pt; margin-left: 7pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 5</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z59d5fece3c56446cb85425d19cfacaa9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Ratio between fixed and variable compensation</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">This Policy aims, among other things, to incentivize the Executives to meet the Company&#8217;s targets while discouraging assumption of
      excessive risk. Accordingly, this Policy set balances between the fixed compensation (annual base salary) and variable compensation (cash bonuses and equity based compensation per annum) to be granted to Executives. As reflected in this Policy, the
      Company&#8217;s target is that the ratio between the fixed compensation and variable compensation will be within the following ranges:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.7pt; margin-left: 7pt; line-height: 1.25;">For Executives other than the CEO: The fixed compensation shall be within the range of 43% to 100% of the overall Executive&#8217;s potential
      compensation, and the variable compensation shall be within the range of 0% to 57% of the Executive&#8217;s overall potential compensation.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.75pt; margin-left: 7pt; line-height: 1.25;">For the CEO: The fixed compensation shall be within the range of 33% to 100% of the overall CEO&#8217;s potential compensation, and the
      variable compensation shall be within the range of 0% to 66% of the CEO&#8217;s overall potential compensation.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-left: 43pt; line-height: 1.25;">(*) The value of the Equity-Based Compensation is calculated as stated in section 4 above.</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zfb8ed52f7a8640aba872b9c20302926c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Separation Arrangements</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.85pt; margin-left: 7pt; line-height: 1.25;">The advance notice period prior to termination shall be determined individually with respect to each Executive, taking into
      consideration the parameters set forth in Section A.2 above. The advance notice period for any Executive shall not exceed the maximum limit set forth in this section below.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.85pt; margin-left: 7pt; line-height: 1.25;">During the advance notice period, the Executive will continue to perform his or her duties to the Company; However, the Company may
      relieve an Executive from his/her duties and responsibilities during the advance notice period and pay the Executive compensation for the advance notice period, including, for avoidance of doubt, acceleration of vesting of Equity-Based Compensation
      which is scheduled to vest during such advanced notice period. The Company may terminate Executive&#8217;s employment without any advance notice in any event which entitles the Company under the law to terminate Executive employment without paying the full
      amount of severance.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.85pt; margin-left: 7pt; line-height: 1.25;">Any pension and severance funds, for which the Company contributed money during the Executive&#8217;s employment with the Company, shall be
      released and owned by the Executive following the end of his or her employment with the Company. Additionally, Executive shall be entitled to any payments and benefits due to him or her under applicable law.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.85pt; margin-left: 7pt; line-height: 1.25;">Additionally, the Company may grant an Executive a separation grant subject to the limitations set out herein. When determining any
      separation arrangement, the Company will consider, among other things, the following: the period of service or employment of the Executive with the Company, his/her terms of service and employment during this period, the Company&#8217;s performance during
      the period, the contribution of the Executive in achieving the Company&#8217;s goals and its profitability, and the circumstances of termination. The Company shall not grant a separation grant to an Executive unless he or she provided services to the
      Company for a period of not less than 24 months.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.9pt; margin-left: 7pt; line-height: 1.25;">In any event, the amount or value of a separation grant together with the base salaries payable during the notice period granted in the
      aggregate to an Executive, other than the CEO, shall not exceed such Executive&#8217;s base salary for six (6) months. Such amount or value of a separation grant together with the base salaries payable during the notice period granted in the aggregate to
      the CEO shall not exceed the CEO&#8217;s base salary for nine (9) months.</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.9pt; margin-left: 7pt; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 6</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z6b6cb66e33a34551a8651faf3c9456de" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 42.95pt;"><br>
          </td>
          <td style="width: 36.05pt; vertical-align: top;">7.</td>
          <td style="width: auto; vertical-align: top;">
            <div><u>Insurance, Exculpation and Indemnification</u></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">The Executive Officers of the Company shall be entitled to benefit from the exculpation and indemnification arrangements as approved from
      time to time by the Company, pursuant to the provisions of the Articles of Association of the Company and applicable law. The Executive Officers will be covered by directors and officers&#8217; liability insurance in such scope and such terms as shall be
      determined from time to time by the Company pursuant to the requirements of applicable law.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.65pt; margin-left: 7pt; line-height: 1.25;">The maximum coverage of such insurance shall be in amounts as determined by the Board and shall not exceed $40 million. The premium
      payable with respect to such insurance and the deductible shall be in market terms and in an amount not material to the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.35pt; margin-right: 15.85pt; margin-left: 7pt; line-height: 1.25;">The Company may purchase insurance cover for Executive Officers of the Company which will also include run-off arrangements for a period
      of up to 7 years from the date of the termination of their tenure as Executive officers of the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-left: 43pt; line-height: 1.25;"><font style="font-weight: bold;">C.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-weight: bold;"><u>General</u></font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.9pt; margin-left: 7pt; line-height: 1.25;">Any entitlements, grants and payments to officers referred to in this Policy shall be approved by the Compensation Committee and the
      Board of Directors (unless otherwise is required by the Companies law), and if applicable under the Companies Law, subject to approval of the General Meeting of shareholders.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">The Compensation Committee and the Board of Directors shall review the Executive Compensation Policy from time to time. In doing so, the
      Compensation Committee and the Board of Directors shall consider the parameters set out in this policy and in the Companies Law and will review and assess any changes in such parameters.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">The term of this Policy shall be three years as of the date of its adoption.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 35.95pt; margin-right: 15.8pt; margin-left: 7pt; line-height: 1.25;">This Policy does not grant any rights to the Company&#8217;s Directors and Executives, and the adoption of this Policy per se does not grant
      any of the Company&#8217;s Directors and Executives a right to receive any type of compensation set forth in this Policy. The compensation items to which a Director or Executive will be entitled will be exclusively these that are expressly granted to him
      or her under a binding instrument in accordance with the requirements of the Companies Law and as approved by relevant authorized organs of the Company.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 7</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; margin-right: 95.55pt; margin-left: 109.45pt; line-height: 1.25; font-weight: bold;">GILAT SATELLITE NETWORKS LTD.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; margin-right: 95.55pt; margin-left: 109.45pt; line-height: 1.25; font-weight: bold;">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-right: 5.1pt; margin-left: 5pt; line-height: 1.25;">The undersigned hereby appoints Amiram Boehm, Doron Kerbel, and Gil Benyamini, or any of them, attorneys or attorney-in-fact, for and in the name(s) of the
      undersigned, with power of substitution and revocation in each to vote any and all ordinary shares, nominal value NIS 0.20 per share, of Gilat Satellite Networks Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), which the undersigned
      would be entitled to vote as fully as the undersigned could if personally present, held of record in the name of the undersigned at the close of business on July 16, 2025, at the Annual General Meeting of Shareholders of the Company to be held on
      August 14, 2025 at 12:00 p.m. Israel time at the offices of the Company, 21 Yegia Kapayim Street, Kiryat Arye, Petah Tikva 4913020, Israel, and at any adjournment or adjournments thereof (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;), hereby
      revoking any prior proxies to vote said shares, upon the following items of business more fully described in the notice of and proxy statement for such Annual General Meeting (receipt of which is hereby acknowledged).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-left: 5pt; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED AS SPECIFIED.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Continued and to be signed on the reverse side)</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <br>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; text-align: center;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">ANNUAL GENERAL MEETING OF SHAREHOLDERS OF </div>
    <div style="text-indent: -22.5pt; margin-right: 127.65pt; margin-left: 153pt; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">GILAT SATELLITE NETWORKS LTD.</div>
    <div style="line-height: 1.25; text-align: center;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">August 14, 2025</div>
    <div style="line-height: 1.25; text-align: center;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">&#160;&#160;&#160;IMPORTANT NOTICE REGARDING THE INTERNET </font></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">AVAILABILITY OF PROXY MATERIALS FOR THIS ANNUAL </font></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">GENERAL MEETING OF SHAREHOLDERS.&#160; THE PROXY</font></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"> STATEMENT IS AVAILABLE AT: OF INTERNET AVAILABILITY </font></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;">OF PROXY MATERIAL:</font></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;<font style="font-weight: bold;">https://www.gilat.com/investor-relations/#sec</font></div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Please date, sign and mail</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">your proxy card as soon</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">as possible.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">In accordance with the Israeli Companies Regulations (Reliefs for Companies with Securities Listed on Foreign Stock Exchanges), 5760-2000, a shareholder submitting a vote for each of Item No. 4, 5, 6 and 7 is deemed to
      confirm to the Company that such shareholder does not have a &#8220;Personal Interest&#8221; in such Item and is not a &#8220;Controlling Shareholder&#8221; (as such terms are defined under the Israeli Companies Law, 5759-1999), unless such shareholder had delivered the
      Company a notice in writing stating otherwise, no later than 10 a.m., Israel time, on August 14, 2025, to the attention of the Company&#8217;s Corporate Secretary, at our registered office in Israel, 21 Yegia Kapayim St., Kiryat Arye, Petah Tikva 4913020,
      Israel.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 73.75pt; margin-left: 109.45pt; line-height: 1.25; font-weight: bold;">Please detach along perforated line and mail in the envelope provided.</div>
    <div style="text-align: center; margin-right: 73.75pt; margin-left: 109.45pt; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-right: 1.65pt; margin-left: 5pt; line-height: 1.25;">THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE APPROVAL OF THE PROPOSALS UNDER ITEMS 1, 2, 3, 4, 5, 6, 7 and 8.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 5pt; line-height: 1.25;">PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-left: 5pt; line-height: 1.25; font-weight: bold;">Items No. 4, 5, 6 and 7 require an indication of &#8220;Personal Interest&#8221; in the resolution and whether the undersigned is a &#8220;Controlling Shareholder&#8221; (as such terms are defined under the
      Israeli Companies Law, 5759-1999 (the &#8220;ICL&#8221;)).</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-right: 1.65pt; margin-left: 5pt; line-height: 1.25; font-weight: bold;">For information regarding the definitions of &#8220;Personal Interest&#8221; and &#8220;Controlling Shareholder&#8221;, please see the explanation in the Notice of Annual General
      Meeting of Shareholders and in the Proxy Statement.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="zff27634b3d20462eab98d640c5d6645d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div>To set the number of Directors on the Board of Directors at eight;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <div>
        <table cellspacing="0" cellpadding="0" id="zd1f6e1ad5e114f3c8b03d6d2fd82c68e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 40.95pt;"><br>
              </td>
              <td style="width: 44.55pt; vertical-align: top; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
              <td style="width: 58.5pt; vertical-align: top; font-weight: bold;">FOR</td>
              <td style="width: auto; vertical-align: top;"><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">AGAINST &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </font><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">ABSTAIN</font></td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z20834b75346d450786d9aa2746177b61" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5pt;"><br>
          </td>
          <td style="width: 35.95pt; vertical-align: top;">(2)</td>
          <td style="width: auto; vertical-align: top;">
            <div>To re-elect four members of the Board of Directors and elect one new member of the Board of Directors to serve until our next annual general meeting of shareholders and until their successors have been duly elected and qualified</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-left: 45pt;">
      <table cellspacing="0" cellpadding="1" border="0" id="z62182d37f65e4ef996032890395616e7" style="width: 70%; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; text-align: left;">

          <tr>
            <td style="width: 54.98%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">&#160;</td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-right: 11.4pt; margin-left: 9.05pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">FOR</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-right: 7.2pt; margin-left: 11.4pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">AGAINST</div>
            </td>
            <td style="width: 14.99%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-right: 1.45pt; margin-left: 6.8pt; line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ABSTAIN</div>
            </td>
          </tr>
          <tr>
            <td style="width: 54.98%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="margin-left: 2.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">a.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Amiram Boehm (re-elect)</font></div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-right: 2.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-left: 4.2pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="width: 14.99%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-left: 5.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 54.98%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-indent: -82.5pt; margin-right: 22.65pt; margin-left: 85pt; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">b.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Aylon
                  (Lonny) Rafaeli (re-elect)</font></div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-right: 2.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-left: 4.2pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="width: 14.99%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-left: 5.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 54.98%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="margin-left: 2.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">c.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Dafna Sharir (re-elect)</font></div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-right: 2.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-left: 4.2pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="width: 14.99%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-left: 5.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 54.98%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="margin-left: 2.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">d.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Amir Ofek (re-elect)</font></div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-right: 2.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-left: 4.2pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="width: 14.99%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-left: 5.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
          </tr>
          <tr>
            <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: top; width: 54.98%;">
              <div style="margin-left: 2.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman', Times, serif;">e.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif;">Dana Porter Rubinshtein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(elect)</font></div>
            </td>
            <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: middle; width: 15%;">
              <div style="text-align: center; margin-right: 2.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-top: 1px solid #000000; vertical-align: middle; width: 15%;">
              <div style="text-align: center; margin-left: 4.2pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
            <td style="border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; border-top: 1px solid #000000; vertical-align: middle; width: 14.99%;">
              <div style="text-align: center; margin-left: 5.35pt; line-height: 1.25; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z346254551ee841608e460b32525e4000" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5pt;"><br>
          </td>
          <td style="width: 35.95pt; vertical-align: top;">(3)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to her election pursuant to Item 2, to approve a grant of options to Dana Porter Rubinshtein, as described in the Proxy Statement</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.95pt;"><br>
                </td>
                <td style="width: 44.55pt; vertical-align: top; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
                <td style="width: 58.5pt; vertical-align: top; font-weight: bold;">FOR</td>
                <td style="width: auto; vertical-align: top;"><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">AGAINST &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </font><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">ABSTAIN</font></td>
              </tr>

          </table>
        </div>
      </div>
      <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z272b02ddbc4e4c1fbe1dc80502ae6acf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5pt;"><br>
          </td>
          <td style="width: 35.95pt; vertical-align: top;">(4)</td>
          <td style="width: auto; vertical-align: top;">
            <div>To approve of the election of Hilla Haddad Chmelnik to serve as an external director for a three-year period commencing as of the date of approval</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.95pt;"><br>
                </td>
                <td style="width: 44.55pt; vertical-align: top; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
                <td style="width: 58.5pt; vertical-align: top; font-weight: bold;">FOR</td>
                <td style="width: auto; vertical-align: top;"><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">AGAINST &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </font><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">ABSTAIN</font></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z746a35b096f441c49cdd43ae3c20b5d2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5pt;"><br>
          </td>
          <td style="width: 35.95pt; vertical-align: top;">(5)</td>
          <td style="width: auto; vertical-align: top;">
            <div>Subject to her election pursuant to Item 4, to approve a grant of options to Hilla Haddad Chmelnik, as described in the proxy statement</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.95pt;"><br>
                </td>
                <td style="width: 44.55pt; vertical-align: top; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
                <td style="width: 58.5pt; vertical-align: top; font-weight: bold;">FOR</td>
                <td style="width: auto; vertical-align: top;"><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">AGAINST &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </font><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">ABSTAIN</font></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="zef730b7d8f3a437dbebc1b3e54b17c41" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5pt;"><br>
          </td>
          <td style="width: 35.95pt; vertical-align: top;">(6)</td>
          <td style="width: auto; vertical-align: top;">
            <div>To amend the Company&#8217;s Compensation Policy for Executive Officers and Directors, as described in the Proxy Statement</div>
          </td>
        </tr>

    </table>
    <br>
    <div style="line-height: 1.25;">
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 40.95pt;"><br>
              </td>
              <td style="width: 44.55pt; vertical-align: top; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
              <td style="width: 58.5pt; vertical-align: top; font-weight: bold;">FOR</td>
              <td style="width: auto; vertical-align: top;"><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">AGAINST &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </font><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">ABSTAIN</font></td>
            </tr>

        </table>
      </div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7f1bca0242b74b349a0d1fb2fcd0c233" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5pt;">
            <div><br>
            </div>
          </td>
          <td style="width: 36pt; vertical-align: top;">(7)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Subject to the amendment of the Company&#8217;s Compensation Policy for Executive Officers and Directors pursuant to Item No. 6, to approve the grant of Performance Stock Units (PSU) to Mr. Adi Sfadia, the Company&#8217;s Chief Executive Officer, as
              described in the Proxy Statement</div>
          </td>
        </tr>

    </table>
    <div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.95pt;"><br>
                </td>
                <td style="width: 44.55pt; vertical-align: top; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
                <td style="width: 58.5pt; vertical-align: top; font-weight: bold;">FOR</td>
                <td style="width: auto; vertical-align: top;"><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">AGAINST &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </font><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">ABSTAIN</font></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z84459043b21040e88df31b45eac211f8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 5pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top;">(8)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To ratify and approve the reappointment and compensation of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as our independent registered public accountants for the fiscal year ending December 31, 2025, and for such
              additional period until the next annual general meeting of shareholders.</div>
          </td>
        </tr>

    </table>
    <div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 40.95pt;"><br>
                </td>
                <td style="width: 44.55pt; vertical-align: top; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</td>
                <td style="width: 58.5pt; vertical-align: top; font-weight: bold;">FOR</td>
                <td style="width: auto; vertical-align: top;"><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">AGAINST &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; </font><font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font>&#160;<font style="font-weight: bold;">ABSTAIN</font></td>
              </tr>

          </table>
        </div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="margin-left: 5pt; line-height: 1.25;">To change the address on your account, please check the box at the right and indicate your new address in the address space above. Please note that changes to account&#8217;s registered name(s) may not be
      submitted via this method. <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="margin-left: 5pt; line-height: 1.25;">Signature of Shareholder <u>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;</u>&#160;&#160; Date <u>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160; </u>Signature of Shareholder&#160;<u>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;
        &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;</u>&#160;&#160;&#160;&#160; Date&#160;<u>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160; </u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-right: 6.6pt; margin-left: 5pt; line-height: 1.25; font-weight: bold;">Note: Please sign exactly as your name or names appear on this Proxy. When shares are held jointly, each holder should sign. When signing as executor,
      administrator, attorney, trustee or guardian, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in
      partnership name by authorized person.</div>
    <div style="margin-right: 6.6pt; margin-left: 5pt; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
